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reactions of biocatalytically desymmetrised
renewable inputs†
Lisa Moni, a Luca Banfi, a Daniele Cartagenova, a Andrea Cavalli, b,c
Chiara Lambruschini, a Elisa Martino, a Romano V. A. Orru, d Eelco Ruijter, d
Jordy M. Saya, d Jacopo Sgrignani b,c and Renata Riva *e
2,5-Bis(hydroxymethyl)tetrahydrofuran, a renewable building block, has been efficiently desymmetrised to
give either enantiomers of the corresponding monobutyrate in high ee exploiting a biocatalytic method-
ology. The aldehydes derived from these monoesters have been subjected to a series of diastereo-
selective Passerini reactions. Careful optimization of reaction conditions has allowed for the increase of
the dr from 1.5 : 1 to 9 : 1. The best results were obtained with zinc(II)-mediated reactions. In particular, a
new modification of Passerini reaction that employs zinc dicarboxylates has been introduced.
Introduction
While most organic syntheses still rely on building blocks
derived from oil or other fossil feedstock, there is a growing
awareness that the scientific community should make all
efforts to shift to renewable sources instead.1–3 Moreover,
Europe, the USA and other countries are implementing fiscal
incentives to promote the production of bio-based materials
and fine chemicals. The most abundant and useful biomass is
certainly wood, which, importantly, is not in competition with
food crops. According to a list recently published by the US
Department of Energy (DOE),4 5-hydroxymethylfurfural
(5-HMF) 1 is one of the twelve most important building blocks
that can be obtained from lignocellulosic biomass (Scheme 1).
It is indeed derived from acid dehydration of hexoses.5 An oxi-
dized derivative of 1 (2,5-furandicarboxylic acid) is already
used for the production of a new bio-based polyester which is
expected to replace PET for beverage plastic bottles.4 On the
other hand, catalytic hydrogenation of 1 furnishes, depending
on the reaction conditions, either 2,5-bis(hydroxymethyl)furan
2 or cis-2,5-bis(hydroxymethyl)tetrahydrofuran (BHMTHF, 3)
(Scheme 1).6,7 The latter has already found practical appli-
cations as a solvent, monomer, and also for the production of
various high-value chemicals such as 1,6-hexanediol and
caprolactam.7,8 However, its use as starting material for more
complex, chiral products, e.g. heterocycles, is still largely
unexplored.
Some of us have been involved, in recent years, in the trans-
formation of renewable building blocks into complex hetero-
cyclic systems,9 applying “green” methodologies. For this
purpose, we are taking advantage of the powerful integration
of multicomponent reactions (MCRs) with biocatalysis. This
fruitful combination10 was first proposed by Ostaszewski
and coworkers11 and since then used by various research
groups,12–17 including ours.18–29
From a green chemistry perspective, while the use of renew-
able starting materials, the implementation of MCRs30 and the
practice of biocatalysis31–33 all represent desirable approaches,
the union of these three in a single integrated, general strategy
can boost their individual beneficial impact on sustainable
synthesis. In this paper, we provide an example of this strategy,
which makes use of biocatalysis as well as the Passerini multi-
component reaction for the stereoselective transformation of
BHMTHF (3) into chiral, relatively complex, depsipeptides.
Also disclosed herein are modification of the Passerini reac-
tion, based on the use of zinc derivatives.
Scheme 1 5-HMF 1 and its derivatives.
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Results and discussion
We first studied the enzymatic desymmetrization of BHMTHF 3.
For the laboratory scale preparation of 3, a diol industrially
produced by hydrogenation of 1 under high pressure,7 we per-
formed the diastereoselective oxidation of 1,5-hexadiene using
NaIO4 under the catalysis of RuCl3 as reported by Stark and
coworkers.34 The enzymatic monoacylation of 3 was not pre-
viously reported while the enzymatic monohydrolysis of its die-
sters,35 such as dibutyrate 5 or the corresponding diacetate, was
known.36–38 After a series of thorough optimization studies, we
found that this desymmetrization could be best performed
using vinyl butyrate in diisopropyl ether at 0 °C, with the cataly-
sis of Amano PS lipase supported on Celite (Scheme 2).39 Under
these conditions, monobutyrate (−)-4 was obtained in good iso-
lated yield (80%) with an excellent ee of 96%.
However, on scaling up the reaction to multigram quan-
tities, the reaction turned out to be rather erratic. Although the
ee remained high, the reaction time needed to reach the
desired conversion (50–55%) varied significantly (from a few
hours to more than a day), depending on the batch of the diol
employed. Eventually, we found that use of a 4 : 1 iPr2O–
CH2Cl2 mixture as the cosolvent and addition of powdered 3 Å
molecular sieves rendered the process highly reproducible.
Under these optimized conditions, the reaction provides 96%
ee at 50% conversion40 (82% yield) or 99% ee at 59% conver-
sion40 (72% yield).
In order to have access to the opposite enantiomer as well,
we next studied the enzymatic hydrolysis of diesters of 3. With
the diacetate using different enzymes, the maximum ee was
only 86% in our hands. In contrast, a satisfactory ee of 92.4%
was obtained in the reaction of dibutyrate 5 using Amano M
lipase from Mucor javanicus, an observation in line with the
previous work by Prasad and coworkers.37
Thus, both enantiomers of 4 were accessible in high ee, of
which the (−)-enantiomer derived from the enzymatic
acylation, was used for the subsequent study on application in
multicomponent reactions. Among the various MCRs, the
Passerini reaction was selected for use of the renewable chiral
building block 4. Thus, we investigated the sequence of oxi-
dation of (−)-4 and reaction of 6 (Table 1). Initially, following
our previous work on desymmetrized erythritol derivatives,22
we used a one-pot protocol, in which 4 was oxidized with cata-
lytic TEMPO and stoichiometric PhI(OAc)2 and treated with
tert-butyl isocyanide. In this in situ Passerini process, in which
the acetic acid by-product from the PhI(OAc)2 oxidant acted as
the carboxylic component, acetoxy amide 7a was produced in
excellent yield, but with poor diastereoselectivity (<1.5 : 1)
(entry 1, Table 1). Since the reaction was quite fast, we hoped
to increase the dr by lowering the temperature. However, per-
forming the reaction at −78 °C gave no improvement, leading
only to a decrease of the isolated yield (entry 2). It was also
found that the solvent had only little influence on the dr
(entries 3–6).
We then decided to investigate the possible beneficial effect
of a Lewis acid additive. We reasoned that the Lewis acid could
be chelated by the carbonyl and ethereal oxygen atoms of 6,
leading to a more rigid transition state.42 In the event, as
noted in our previous work on erythritol derivatives,22 zinc
halides emerged as efficient promoters, with ZnBr2 being the
best (entry 10 vs. entries 7 and 8).
A series of solvent screening experiments was then per-
formed, in which remarkable increase of diastereoselectivity
was noted on going from CH2Cl2 (entry 11) to ethereal sol-
vents, especially diisopropyl ether (entry 14). Interestingly,
addition of 10% cosolvent turned out to be slightly deleterious
(entry 15) while reducing catalyst loadings from 1 to 0.4
equivalents did not lower the diastereoselectivity or yield
(entry 16).
Next, we investigated the effect of the order of addition of
the reagents. Based on our initial hypothesis that the role of
the zinc reagent might be chelation with aldehyde 6, we tried
slow addition of the isocyanide (or the mixture of the isocya-
nide and carboxylic acid) to a premixed solution of aldehyde 6
and ZnBr2 (entry 17). However, to our surprise, this led to
decrease in both the dr and yield. We eventually found that
the optimal procedure, unexpectedly, involved slow addition of
the aldehyde and carboxylic acid mixture to the premixed solu-
tion of the isocyanide and ZnBr2 despite longer reaction times
(entries 19 and 20).
In practicing the procedure on preparative scales, however,
the yields of both the oxidation and Passerini reactions were
found to be highly variable. Noting the strong tendency of
aldehyde 6 to form a hydrate, likely stabilized by the adjacent
THF oxygen, we surmised that the presence of water might
cause the over-oxidation and lower the yield of the ZnBr2 cata-
lysed Passerini reaction. Indeed, performing the oxidation
using the Swern methodology gave a nearly quantitative yield
of the aldehyde. In addition, we found further drying of the
aldehyde by freshly activated molecular sieves or azeotropic
removal of water to be beneficial. Under these optimized con-
ditions, the two-step reaction became reproducible, giving rise
to 7a as a 81 : 19 mixture of anti and syn diastereomers (entryScheme 2 Desymmetrization of meso diol 3 and diester 5.
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21). Thus, it was shown to be feasible to improve the diaster-
eoselectivty of an isocyanide-based MCR, a process known for
poor stereoselectivity, by modifying the reaction conditions.22
The results of entries 17, 19 and 20 (experiments regarding
the order of addition of reagents) disputed our initial hypoth-
esis of zinc(II) chelation. Furthermore, the stereochemical ana-
lysis of the major isomer contradicted this hypothesis. In
order to determine the absolute configuration of the stereocen-
ter formed by the Passerini reaction, our attempts were initially
focused on the preparation of Mosher esters of the secondary
alcohol of 7a.43 Due to the difficulty in selective deprotection,
however, we turned to the synthesis of the PMP protected
alcohol (2R,5S)-8 from (2R,5S)-4 by protecting group exchange
as described in Scheme 3. Thus, the desymmetrised alcoholic
ether (cf. 8), rather than ester (cf. 4), was subjected to the
sequence of oxidation and Passerini reactions to give a mixture
of anti and syn diastereomers, each of which was hydrolysed
and reacted with both enantiomers of Mosher’s chlorides. 1H
NMR analyses of these four Mosher’s esters assigned the
major diastereomer of 9 to be of (2R) (and thus anti) configur-
ation and that of the minor diastereomer of 9 to be of (2S)
(and thus syn) configuration. Then, anti-9 was correlated to
anti-7a via conversion into the corresponding diols (2R,2′R,5′
S)-anti-ent-10 and (2S,2′S,5′R)-anti-10, respectively. These two
enantiomers gave superimposable NMR spectra, whereas the
spectrum of syn-10 was clearly different.44
Having established the stereochemical outcome, we revised
our mechanistic rationale as shown in Scheme 4. This propo-
sal is also based on the observation that ZnBr2, which is
usually insoluble in iPr2O, is partly dissolved when mixed with
t-butyl isocyanide. We believe that the formation of a complex
such as 12 might represent the first step, which a recent report
that ZnBr2 could even form a complex with two isocyanides
lends support to.45 There could be an equilibrium between 12
and ZnBr2(CN-R)2, together with an exchange process with
acetic acid that can lead to monoacetate 13, which may be the
real reacting species. With this backdrop, the chelated tran-
sition state I, which we initially hypothesized, would favour
the syn product due to the steric encumbrance of the lower car-
bonyl face. Also in discord with the chelation model is the
finding that pre-mixing ZnBr2 and the aldehyde has a deleter-
ious effect. Thus, it is more reasonable to assume that the zinc
Table 1 Optimization of the diastereoselectivity in the Passerini reaction to give 7a a
Entry Prep. of 6 b Solvent Additive (equiv.) Mode of additionc Temp (°C) Time (min) Yieldd (%) dr (anti : syn)e
1 A THF/CH2Cl2 1 : 1 None D 20 40 93 59 : 41
2 A THF/CH2Cl2 1 : 1 None D −78 205 27 58 : 42
3 B CH2Cl2 None D 20 60 96 59 : 41
4 B THF None D 20 60 77 62 : 38
5 B Et2O None D 20 60 74 62 : 38
6 B iPr2O None D 20 90 94 62 : 38
7 A THF/CH2Cl2 1 : 1 ZnCl2 (1) D 20 60 59 63 : 37
8 A THF/CH2Cl2 1 : 1 ZnI2 (1) D 20 60 85 64 : 36
9 A THF/CH2Cl2 1 : 1 ZnI2 (1) D −78 120 36 65 : 35
10 A THF/CH2Cl2 1 : 1 ZnBr2 (1) D 20 40 60 71 : 29
11 B CH2Cl2 ZnBr2 (1) D 20 60 32 64 : 36
12 B THF ZnBr2 (1) D 20 60 56 71 : 29
13 B Et2O ZnBr2 (1) D 20 60 78 72 : 28
14 B iPr2O ZnBr2 (1) D 20 90 85 76 : 24
15 B iPr2O/THF 9 : 1 ZnBr2 (1) D 20 90 80 72 : 28
16 B iPr2O ZnBr2 (0.4) D 20 120 85 76 : 24
17 B iPr2O ZnBr2 (0.4) E 20 180 57 72 : 28
18 B iPr2O ZnBr2 (0.4) F 20 180 68 80 : 20
19 B iPr2O ZnBr2 (0.4) G 20 180 88 79 : 21
20 B iPr2O ZnBr2 (0.4) G 20 180 77
f 79 : 21
21 C iPr2O ZnBr2 (0.4) G 20 260 82
f 81 : 19
a This table shows some selected results, but the full set of optimization data can be found in the ESI.† b A: Oxidation was performed with
TEMPO/PhI(OAc)2, and the following Passerini reaction was carried out in a one-pot manner. Yield of both diastereomers determined based on
alcohol 4; B: oxidation was performed with TEMPO/PhI(OAc)2, and aldehyde 6 was purified by chromatography. Yield based on aldehyde 6; C:
aldehyde 6 obtained from Swern oxidation was purified by chromatography and thoroughly dried over molecular sieves. Yield determined based
on aldehyde 6. cD: All reagents were added together; E: isocyanide added slowly (during 2 h) to the mixture of aldehyde, ZnBr2 and carboxylic
acid; F: aldehyde added slowly (during 2 h) to the mixture of isocyanide, ZnBr2 and carboxylic acid; G: aldehyde and carboxylic acid mixed
together and added slowly (during 2 h) to the mixture of isocyanide and ZnBr2.
dOverall yield of the two diastereomers. NMR yield was deter-
mined by 1H NMR of the crude in the presence of 2,5-dimethylfuran as internal standard. eDetermined by 1H NMR analysis on the crude
product. f Isolated yield.
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centre is coordinated by the aldehyde and the isocyanide,
allowing a concerted intramolecular mechanism as shown in
transition states II–IV. The formation of anti products could be
preferred by a typical Felkin–Anh model such as IV. However,
the butyryloxymethyl arm would impose a severe steric strain
to the zinc catalyst. Moreover, the Felkin–Anh model is based
on the Bürgi–Dunitz trajectory, whereas the trajectory in our
case, if the concerted mechanism is operative, should be
closer to 90°. Thus, we think that transition states II and III,
with the aldehyde group placed “outside” the THF ring, would
be more favoured. Again, the orientation of the butyryloxy-
methyl group is expected to favour II, leading to the anti
isomer.
The same transition state is likely to be favoured under
“normal” Passerini conditions, but the increased selectivity
with the zinc modifications may be due to the more rigid tran-
sition states and the higher steric demand of the carboxylate
group. The slow addition of the aldehyde and acid com-
ponents may be beneficial, limiting the “normal” Passerini
reaction. It should be noted that the rates of Passerini reac-
tions are very similar with or without ZnBr2 additive. In
addition, involvement of two molecules of the carboxylic acid
in the transition state has been put forward by the recent
mechanistic studies by Morokuma et al.46,47 Thus, high
dilution of the carboxylic acid, a possible setting under con-
dition G (entries 19–21, Table 1), may be beneficial in suppres-
sing the “normal” mechanism.
Having found the optimal conditions for the model system,
we set out to examine the isocyanide and carboxylic acid com-
ponents. Our effort to expand the scope of the reaction,
however, met with two problems: (1) poor solubility of several
carboxylic acids in iPr2O and (2) formation of side-products. In
particular, as shown in Scheme 5, alcohol side-product 15b,
Scheme 3 Determination of absolute configuration of the new stereo-
genic centre.
Scheme 4 Rationalisation of stereochemical results.
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albeit formed in small amounts (3.5–7%), posed major
difficulty in the analysis of the reaction outcome and purifi-
cation of the product.48 The dryness of aldehyde 6 was found
to affect the yield of the alcohol diastereomers 15b.
Interestingly, the dr was about 1 : 1, indicating that they did
not derive from a hydrolysis of 7a, but, instead, from an inde-
pendent process. While these side-products were never
detected under classical Passerini conditions, Lewis acids were
known to promote the generation of these so-called “trun-
cated” Passerini products without incorporation of a carboxylic
acid via the intermediacy of 17 as shown for ZnBr2
(Scheme 6).49
Based on this rationale, we decided to investigate the use of
a preformed zinc carboxylate. It was anticipated that such a
zinc salt could promote the reaction while suppressing both
the “normal” and “truncated” Passerini reactions. Free from
these two reactions, the factors affecting the reaction (solvent,
slow addition, etc.) could be less important. Thus, the optimiz-
ation study on the reaction in Scheme 5 was performed using
isocyanide 14 and acetic acid (entries 4–6, Table 2). With stoi-
chiometric Zn(OAc)2 (condition C) instead of catalytic ZnBr2
(condition B), the reaction was considerably slower, in part
because of the insolubility of Zn(OAc)2 in organic solvents.
However, the formation of truncated products was almost com-
pletely suppressed, especially when aldehyde 6 was thoroughly
dried over molecular sieves. Moreover, the diastereoselectivity
was essentially the same, with the yield of 7b higher. A poss-
ible mechanism is shown in Scheme 6.
A set of solvent screening studies revealed CHCl3 to be
optimal for the reaction with zinc acetate at 40 °C for 4.5 h.
The work-up conditions were found to be important to obtain
high yield. At the end of the reaction, treatment of the precipi-
tates with 1 M HCl prior to extraction was necessary for com-
plete recovery of the material, presumably because the release
of 7b from the zinc derivative 19 or 20 required an acid.
The slower rate, compared to that of the ZnBr2 catalyzed
process, could be due to the poor solubility of Zn(OAc)2 and
also to its milder Lewis acid character, which might influence
the complexation equilibrium with the isocyanide and/or the
aldehyde. In the case where 0.4 equivalents of Zn(OAc)2 and
stoichiometric acetic acid were used, the reaction was much
faster but gave a 62 : 38 dr, suggesting that the normal
Passerini mechanism competed significantly with the zinc-
mediated pathway.
In addition to the advantage of diastereoselection over the
standard Passerini conditions, the new Passerini reaction with
unprecedented modification is advantageous over the ZnBr2
catalyzed process: (a) “truncated” Passerini products are nearly
suppressed; (b) it is possible to use CHCl3 solvent capable of
dissolving a broad range of reactants; (c) the reaction can be
performed without the need of slow addition; (d) in some
cases the diastereoselectivity may be higher. The disadvan-
tages are: (a) the need to prepare the zinc carboxylates that are
not commercially available; (b) only half of the carboxylic acid
is incorporated in the product.
The scope of the reaction employing zinc carboxylates was
then assessed using different isocyanides and carboxylic acids
(Table 2, method C). For some entries, the reactions under the
classical Passerini conditions (method A) and/or under the
ZnBr2 catalyzed methodology (method B) are presented for
comparison. In nearly all instances, method C is superior to
the ZnBr2 catalysed reaction in terms of the yield and the
ability to suppress the “truncated” Passerini side products.
The two modified protocols employing zinc additives
provide significant improvement in the diastereoselectivity vis-
à-vis the standard Passerini conditions. Method C is particu-
larly more effective with aromatic carboxylates and isocyanides
bearing primary alkyl groups, thus giving a better result than
other methods (cf. entries 7–9). The higher diastereoselection
achieved with aromatic (bulkier) carboxylates agrees with the
Scheme 5 Formation of truncated Passerini adducts.
Scheme 6 Putative mechanism of the zinc dicarboxylate modification.
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rationalization shown in Scheme 4. On the other hand, with
tert-butyl isocyanide diastereoselectivities are slightly lower
using method C compared to method B (entries 2 and 3 vs.
entry 17). For other combinations, the dr values obtained with
methods B and C are similar, but the reactions carried out
with method C are cleaner.
In order to gain more insights in the stereochemical
outcome of the reaction, we carried out theoretical calculations
by using DFT (see Experimental part). First, the conformation-
al analysis of 6 has been performed, revealing that the confor-
mer bearing the aldehyde group “outside” the THF ring
(Scheme 4, T.S. II and III) was the most favoured. Then, this
conformation was used to build a model of the possible tran-
sition states including 6, zinc acetate and methyl isocyanide.
Our results clearly showed that T.S. II, in which the co-
ordinated isocyanide attacks from the opposite face respect to
the tetrahydrofuran ring, is favoured (Fig. 1A). Even when the
isocyanide is placed in the opposite position (as showed in the
T.S. III), the optimization calculations converge on the struc-
tures where isocyanide occupies an equivalent position.
Moreover, the simple observation of the conformations
assumed by 6 in the T.S. II model, in which the atoms are rep-
resented by vdW spheres, clearly suggests that this preference
is due to the steric hindrance produced by the hydrogen atoms
of the CH2 groups present on the tetrahydrofuran ring, rather
than the presence of the butyryloxymethyl group (Fig. 1B).
Based on a recent computational analysis,47 where the authors
proposed that the formation of the nitrilium complex (Fig. 1C)
is the rate-determining step of the reaction, we have calculated
the potential energy profile for the attack of the methyl isocya-
nide to aldehyde 6. As illustrated in Fig. 1D, the energy barrier
to be overcome to obtain the nitrilium intermediate is
11.9 kcal mol−1, demonstrating the feasibility of the process.
The Passerini products described above have two masked
protected alcoholic moieties that can be exploited for further
structural elaborations (Scheme 7). First, selective removal of
the butyryl group from 7a was accomplished to form 21 by
enzymatic hydrolysis using Candida antarctica lipase B
(CAL-B). In contrast to our previous findings concerning the
erythritol derivatives,22 the acetyl group displayed much less
tendency to migrate from the secondary to the primary
alcohol. The diastereomeric mixture of Passerini products 7a
was also hydrolyzed into diols 10, which were converted
directly into bicyclic systems 22 by applying Mitsunobu con-
ditions. The diastereomeric ratio was conserved in this stereo-
specific process (anti-7a to anti-22), due to the selective substi-
tution at the primary alcohol, as observed in our previous
work on erythritol derivatives.22
Table 2 Scope of the modified Passerini reaction to give esters 7
Entry Product R1 R2 Methoda Timeb (min) Yieldc (%) dr (anti : syn)d
1 7a tBu Me A 40 90 59 : 41
2 7a tBu Me B 260 82 81 : 19
3 7a tBu Me C 285 74 71 : 29
4 7b (4-BnO-C6H4)CH2CH2 Me A 60 87 58 : 42
5 7b (4-BnO-C6H4)CH2CH2 Me B 150 64 73 : 27
6 7b (4-BnO-C6H4)CH2CH2 Me C 260 79 76 : 24
7 7c nBu Ph A 120 90 66 : 34
8 7c nBu Ph B 240 52 76 : 24
9 7c nBu Ph C 260 71 90 : 10
10 7d Bn Me B 240 52 83 : 17
11 7d Bn Me C 285 76 79 : 21
12 7e 4-(Allyloxy)-C6H4 Me B 120 68 82 : 18
13 7e 4-(Allyloxy)-C6H4 Me C 255 87 82 : 18
14 7f Me Ph C 90 77 86 : 14
15 7g (4-BnO-C6H4)CH2CH2 Ph C 240 77 84 : 16
16 7h Cyclohexyl PhCH2CH2 C 320 84 74 : 26
17 7i tBu PhCH2CH2 C 270 78 70 : 30
18 7j 1,6-Di-Me-C6H4 ortho-MeC6H4 C 225 77 84 : 16
19 7k tBu ortho-MeC6H4 C 260 60 63 : 37
20 7l nBu ortho-MeC6H4 C 220 78 82 : 18
a A: Standard Passerini reaction with no additives in CH2Cl2 at rt; B: slow addition, at rt, of the mixture of aldehyde 6 and carboxylic acid to the
isocyanide premixed with 0.4 equivalents of ZnBr2 in iPr2O; C: reaction of 6 with the isocyanide and the appropriate zinc dicarboxylate, in CHCl3
at 40 °C. In all cases, aldehyde 6 was chromatographed and then thoroughly dried by overnight treatment with molecular sieves or azeotroping
with toluene. b Reaction were stopped when starting aldehyde completely disappeared. For this reason, reaction times differ depending on reac-
tion conditions and on substrates. c Isolated overall yield of both diastereomers. dDetermined by 1H NMR analysis of the crude product.
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Despite the fact that the Passerini reaction is nearly 100 years
old, very few studies regarding the diastereoselectivity, when
using chiral aldehydes, have appeared in the literature. With
the exception of few cases, poor levels of stereoinduction have
been reported.22,50 In this paper, we have found that it is poss-
ible to achieve significant enhancement in the diastereoselecti-
vey by optimizing reaction conditions. In particular, we have
introduced a new way to perform the Passerini reaction, using
zinc carboxylates. This new modification may be advantageous
with improved diastereoselectivities and of use in difficult
cases where the normal conditions fail. Studies are in progress
to find other useful applications of this new modification and
to apply it to the Ugi reaction.
Experimental section
General methods
NMR spectra were taken at rt in CDCl3 at 300 or 500 MHz (
1H),
and 75 or 126 MHz (13C), using, as internal standard, TMS (1H
NMR: 0.000 ppm) or the central peak of CDCl3 (
13C:
77.02 ppm). Chemical shifts are reported in ppm (δ scale).
Peak assignments were made with the aid of gCOSY, gHSQC
and gHMBC experiments. HPLC-MS-UV analyses were carried
under inverse phase with a Phenomenex Gemini 3µ C6-Phenyl
(150 × 3 mm) column. Detectors: DAD (226 nm), and MS
Microsaic 4000 MiD (ESI ionization, Tic voltage 750, single
quadrupole, FullScan: 100–800 m/z). Quantitative determi-
nation was done with DAD detector, while MS was used to
recognize Passerini and “truncated” Passerini products.
Column temp: 30 °C. Flow: 0.34 mL min−1. Elution was done
with A : B from 90 : 10 to 0 : 100, where (A) = H2O + 1% formic
acid; (B) = CH3CN + 1% formic acid. HRMS: samples were ana-
lysed with a Synapt G2 QToF mass spectrometer. MS signals
were acquired from 50 to 1200 m/z in ESI positive ionization
mode. TLC analyses were carried out on silica gel plates and
viewed at UV (254 nm) and developed with Hanessian stain
(dipping into a solution of (NH4)4MoO4 4 H2O (21 g) and Ce
(SO4)2 4 H2O (1 g) in H2SO4 (31 ml) and H2O (469 ml) and
warming) or with KMnO4. Rf were measured after an elution of
7–9 cm. Column chromatographies were done with the “flash”
methodology using 220–400 mesh silica. Petroleum ether
(40–60 °C) is abbreviated as PE. In extractive work-up, aqueous
solutions were always reextracted three times with the appro-
priate organic solvent. Organic extracts were always dried over
Na2SO4 and filtered, before evaporation of the solvent under
reduced pressure. All reactions using dry solvents were carried
out under a nitrogen atmosphere.
((2R,5S)-5-(Hydroxymethyl)tetrahydrofuran-2-yl)methyl buty-
rate (−)-4. A solution of diol 3 (2.00 g, 15.13 mmol) in dry dii-
sopropyl ether (113 mL) and dry methylene chloride (28 mL),
was treated with vinyl butyrate (9.60 mL, 75.65 mmol) and
freshly activated 3 Å powdered molecular sieves (757 mg). The
mixture was cooled to 0 °C and treated with Amano PS lipase,
Fig. 1 (A) Optimized structures of the energetically favored model built
including aldehyde 6, zinc diacetate and methyl isocyanide. (B)
Representation of the most favoured conformation assumed by 6 rep-
resented using vdW spheres. (C) Structure of the reaction intermediate
obtained by RPES calculations corresponding to the energy minimum at
1.5 Å. The bond more critical for the formation of the intermediate are
showed as smaller sticks and the corresponding Wiberg bond orders are
reported. (D) Energy profile from RPES calculations.
Scheme 7 Some transformations carried out on Passerini products.
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supported on Celite as previously described39 (800 mg, corres-
ponding to 178.4 mg of unsupported enzyme). The suspension
was stirred until disappearance of starting diol, as judged by
TLC. This corresponds to a conversion of about 58–60%,
where conversion is defined as the percentage of acylated
hydroxy groups. Thus conversion = ([5]*2 + [4])/[starting 3]*2.
Typically, this conversion (which can be determined precisely
by 1H NMR of the crude product) is reached after 20 h. The
crude product was filtered through a sintered funnel, washed
with EtOAc/MeOH 9 : 1. In this way, the supported enzyme
could be easily recovered and reused, without loss of activity
(at least for three times). After evaporation of the mother
liquors, chromatografy (PE/EtOAc from 3 : 2 to 1 : 1) gave pure
monobutyrate (−)-4 as a liquid (2.20 g, 72%). Ee was 99%, as
determined by HPLC of the corresponding benzoate on a
chiral stationary phase. Conditions: column Daicel Chiral Pak
AD (250 × 4.6 mm); detector DAD (226 nm). Isocratic elution
with n-hexane/isopropanol 95 : 5. Temperature: 26 °C. Rt (−)
enantiomer: 23.98 min. Rt (+) enantiomer: 22.65 min. [α]D =
−17.1 (c 1.09, toluene). [α]D = −6.3 (c 1.0, CHCl3). Lit. (for
the (+) enantiomer): +16.0 (toluene).37 Rf 0.22 (PE/EtOAc 7 : 3).
1H NMR (300 MHz, CDCl3, 20 °C): δ = 4.25–4.05 (4 H, m,
CH2OCvO, 2-H, 5-H), 3.74 and 3.50 (2 H, AB part of ABX syst.,
JAB = 11.8 Hz, JAX, JBX = 4.9, 3.1 Hz, CH2OH), 2.80 (1 H, br s,
OH), 2.34 (2 H, t, J = 7.4 Hz, CH2CvO), 2.09–1.64 (4 H, m, 3-H,
4-H), 1.66 (2 H, hexuplet, J = 7.2 Hz, CH3CH2), 0.96 (3 H, t, J =
7.3 Hz, CH3).
13C NMR (75 MHz, CDCl3, 25 °C): δ =
173.8 (CvO), 80.4, 77.4 (C-2, C-5), 66.2 (CH2OCO), 64.5
(CH2OH), 36.1 (CH2CvO), 28.0, 26.7 (C-3, C-4), 18.4 (CH2CH3),
13.6 (CH3–CH2). I.R. (ATR): νmax 3450, 2964, 2876, 1733,
1459, 1381, 1305, 1254, 1176, 1078, 1046, 995, 942, 884, 815,
752, 709, 610 cm−1. GC-MS: Rt 6.43 min. M/z: 171 (M
+ − 31,
19%), 114 (8.2), 101 (50), 89 (9.0), 84 (15), 83 (95), 71
(100), 69 (5.8), 59 (6.7), 58 (5.7), 57 (62), 56 (5.1), 55 (45),
45 (5.8), 44 (8.9), 43 (89), 42 (14), 41 (29), 39 (12). HRMS
(ESI+): found 203.1287 [calcd for C10H19O4
+ (M + H)+
203.1283].
((2R,5S)-5-(Butyryloxymethyl)tetrahydrofuran-2-yl)methyl
butyrate 5. A solution of diol 3 (660 mg, 5 mmol) in dry
CH2Cl2 (50 mL) was cooled to 0 °C and treated with Et3N
(3.0 mL, 20 mmol), 4-dimethylaminopyridine (61 mg,
0.5 mmol) and butyryl chloride (1.24 mL, 12 mmol). The
mixture was stirred for 1 h at 0 °C and for 3 h at rt. Then it was
poured into saturated aqueous NaHCO3 (70 mL). The phases
were separated, and the aqueous phase re-extracted twice with
Et2O. The united organic extracts were washed with brine,
evaporated and chromatographed (PE/EtOAc from 4 : 1 to 3 : 2)
to give known37 dibutyrate 5 as a liquid (1.55 g, 88%). Rf = 0.70
(PE/EtOAc 1 : 1). 1H NMR (300 MHz, CDCl3, 20 °C): δ =
4.15–4.07 (4 H, m, CHHOCvO, 2-H, 5-H), 3.95 (2 H, dd, J =
12.4 Hz, J = 7.1 Hz, CHHOCvO), 2.26 (2 H, t, J = 7.4 Hz,
CH2CvO), 2.00–1.86 (1 H, m, 3-H or 4-H), 1.70–1.50 (3 H, m,
3-H or 4-H), 1.59 (4 H, hexuplet, J = 7.5 Hz, CH3CH2), 0.88 (6
H, t, J = 7.4 Hz, CH3).
13C NMR (75 MHz, CDCl3, 25 °C): δ =
173.3 (CvO), 77.2 (C-2, C-5), 65.9 (CH2O), 35.8 (CH2CvO),
27.5 (C-3, C-4), 18.2 (CH2CH3), 13.4 (CH3).
((2S,5R)-5-(Hydroxymethyl)tetrahydrofuran-2-yl)methyl buty-
rate (+)-4. Diburyrate 5 (224 mg, 0.82 mmol) was suspended in
0.5 M pH 7 phosphate buffer (KH2PO4/K2HPO4) (12 mL) and
treated with Amano M lipase (23 mg). The mixture was vigor-
ously stirred for 4 h at rt. Then it was saturated with solid
NaCl, diluted with EtOAc, and filtered through a Celite cake.
After separation of the phases, the aqueous one was re-
extracted twice with EtOAc. The organic extracts were chro-
matographed (PE/EtOAc from 3 : 2 to 1 : 1) to give pure (+)-4 as
a liquid (846 mg, 84%). [α]D = +16.0 (c 1.02, toluene). The
other data were identical to those of (−)-enantiomer. The ee
was determined to be 92.4% by HPLC analysis (for conditions
see the preparation of (−)-4).
((2R,5S)-5-Formyltetrahydrofuran-2-yl)methyl butyrate 6. A
solution of dry DMSO (440 µL, 6.18 mmol) in dry CH2Cl2
(15 mL) was cooled to −78 °C and treated with a 2 M solution
of oxalyl chloride in CH2Cl2 (2.6 mL, 5.2 mmol). After 10 min,
a solution of alcohol (−)-4 (500 mg, 2.47 mmol) in dry CH2Cl2
(6 mL) was added. After 10 min, triethylamine (1.60 mL,
12.0 mmol) was added. After 1 h, when the reaction was
judged complete by TLC, the solution was poured into 30 mL
of 5% aqueous (NH4)H2PO4 + 2 mL of 1 M HCl. The phases
were separated, and the aqueous phase re-extracted twice with
Et2O. The organic phases were washed with saturated aqueous
NaHCO3 and brine. After evaporation, the crude product was
chromatographed (PE/EtOAc 3 : 2) to give, in quantitative yield,
aldehyde 6 as an oil. This aldehyde was used as such for the
Passerini reaction. An analytical sample was obtained by chrom-
atography on thoroughly dried silica gel. 1H NMR (500 MHz,
CDCl3, 20 °C): 9.70 (1 H, d, J = 1.6 Hz, CHvO), 4.37–4.30 (2 H,
m, CH–O), 4.27 (1 H, dd, J = 11.7, 3.5 Hz, CHHO), 4.10 (1 H, dd,
J = 11.7, 5.9 Hz, CHHO), 2.34 (2 H, t, J = 6.1 Hz, CH2CvO),
2.22–2.02 (3 H, m, 3-H, 4-H), 1.72–1.61 (1 H, m, 3-H or 4-H),
1.67 (2 H, sextuplet, J = 7.1 Hz, CH3CH2), 0.96 (3 H, t, J = 7.5 Hz,
CH3).
13C NMR (126 MHz, CDCl3, 25 °C, acquired in J-MOD
pulse sequence): δ 173.5 (CvO), 83.6 (CHO), 78.6 (CHO), 65.9
(CH2O), 36.0 (CH2CvO), 27.64, 27.57 (C-3, C-4), 18.4 (CH2CH3),
13.6 (CH3). I.R. (ATR): νmax 2964, 1732, 1458, 1381, 1364, 1306,
1259, 1178, 1082, 1049, 1001 cm−1. HRMS (ESI+): found
201.1121 [calcd for C10H17O4
+ (M + H)+ 201.1127].
Typical procedure for preparation of zinc carboxylates:
zinc(II) 2-methylbenzoate. NaOH (310 mg, 7.76 mmol) is dis-
solved in deionised water (5 mL) and added, under vigorous
stirring, with 2-methylbenzoic acid (1.06 g, 7.76 mmol). After a
while, a clear solution is obtained. Then, a solution of zinc(II)
chloride (529 mg, 3.88 mmol) in deionized H2O (2 mL) is
slowly dropped. The precipitation of a white solid is observed.
The flask containing the zinc chloride solution is washed
twice with 0.5 mL of water, in order to transfer quantitatively
the salt. After stirring for 2 h, the suspension is left standing
overnight without stirring. The solid is recovered by filtration
on a Büchner funnel and dried in a dessiccator under vacuum
over P4O10. Yield: 1.06 g, 81%. White solid. M.p. =
233.8–235.2 °C. I.r.: νmax 3064, 2969, 2930, 1625, 1605, 1577,
1525, 1434, 1397, 1288, 1199, 1161, 1105, 1051, 1035, 955, 875,
855, 815, 786, 734, 700, 665 cm−1.
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Using the same procedure we prepared zinc benzoate (m.p.
= 313.9–316.2 °C. I.r.: νmax 3062, 3031, 1979, 1914, 1823, 1631,
1595, 1576, 1539, 1526, 1494, 1403, 1312, 1175, 1158, 1102,
1070, 1027, 1003, 976, 938, 865, 842, 819, 712, 695, 684, 675,
606 cm−1) and zinc phenylpropionate (m.p. = 158.1–160.6 °C.
I.r.: νmax 3061, 3031, 2978, 2921, 2866, 1599, 1531, 1498, 1468,
1439, 1404, 1354, 1284, 1251, 1163, 1080, 1031, 960, 910, 832,
784, 749, 730, 697 cm−1.
General conditions for the Passerini reaction. ((2R,5S)-5-((S)-
1-Acetoxy-2-(tert-butylamino)-2-oxoethyl)tetrahydrofuran-2-yl)
methyl butyrate anti-7a and ((2R,5S)-5-((R)-1-acetoxy-2-(tert-
butylamino)-2-oxoethyl)tetrahydrofuran-2-yl)methyl butyrate
syn-7a. Method A. Aldehyde 6 (100 mg, 0.50 mmol) was dis-
solved in dry CH2Cl2 (2.5 mL) and treated with acetic acid
(32 µL, 0.55 mmol) and tert-butyl isocyanide (62 µL,
0.55 mmol). After stirring for 40 min at rt, the mixture was
directly chromatographed (PE/CH2Cl2/acetone 10 : 4 : 1) to give
anti-7a (Rf 0.63, CH2Cl2/PE/EtOAc 3 : 2 : 2) and syn-7a (Rf 0.55)
in 90% overall yield. Dr: 59 : 41. In order to completely separate
the two diastereomers, two chromatographies were needed.
Method B. Aldehyde 6 (100 mg, 0.50 mmol) was further
dried by taking it up with toluene and evaporating (the pro-
cedure was repeated twice). Then it was taken up in iPr2O
(1 mL) and treated with acetic acid (32 µL, 0.55 mmol). This
solution was slowly added, during 2 h, with a syringe pump, to
the mixture of tert-butyl isocyanide (62 µL, 0.55 mmol) and
ZnBr2 (freshly dried at 250 °C) (45 mg, 0.20 mmol) in iPr2O
(1 mL). At the end of addition, the mixture was further stirred
for 140 min. Then the mixture was treated with 1 M HCl
(12 mL) and CH2Cl2 (12 mL) and stirred for 10 min. The
phases were separated, and the aqueous phase re-extracted
twice with CH2Cl2. The organic phases were washed with satu-
rated aqueous NaHCO3, evaporated and chromatographed as
above. Yield: 82%. Dr: 81 : 19.
Method C. Aldehyde 6 (100 mg, 0.50 mmol) was taken up in
dry CHCl3 (1.25 mL), treated with 3 Å molecular sieves (in
rods) (20 mg) and left standing overnight. Then this solution
(without the sieves) was added to zinc diacetate (101 mg,
0.55 mmol) and suddenly treated with tert-butyl isocyanide
(62 µL, 0.55 mmol). Two washings of the flask containing the
aldehyde with little CHCl3 were made in order to transfer all
the aldehyde. The resulting suspension was stirred at 40 °C for
285 min. Then the mixture was treated with 1 M HCl (12 mL)
and CH2Cl2 (12 mL) and stirred for 10 min. The phases were
separated, and the aqueous phase re-extracted twice with
CH2Cl2. The organic phases were washed with saturated
aqueous NaHCO3, evaporated and chromatographed as above.
Yield: 74%. Dr: 71 : 29.
The diastereomeric ratio was determined by 1H NMR, by
integration of the CHOAc signals, at 5.07 (anti) and 5.00 (syn).
No other diastereomers (deriving from epimerization) were
detected in the crude products for none of the three methods.
Also, the polarimetric values of anti and syn products obtained
with the three methods were identical. The absence of racemi-
zation was determined at the level of compounds anti-10 (see
below).
Anti-7a (major). Oil. Rf = 0.63 (CH2Cl2/PE/EtOAc 3 : 2 : 2).
[α]D = −6.5 (c 1.2, CHCl3). 1H NMR (300 MHz, CDCl3, 20 °C):
δ = 6.07 (1 H, br s, NH), 5.07 (1 H, d, J = 5.2 Hz, CHOAc), 4.29
(1 H, td, J = 6.0, 3.5 Hz, 5-H), 4.16–4.09 (1 H, m, 2-H), 4.12 and
4.04 (2 H, AB part of an ABX syst., JAB = 11.5, JAX, JBX = 4.0, 6.0
Hz, CH2O), 2.33 (2 H, t, J = 7.5 Hz, COCH2CH2CH3), 2.17 (3 H,
s, CH3CO), 2.04–1.94 (3 H, m, 3-H, 4-H), 1.74–1.60 (3 H, m, 3-H
or 4-H and COCH2CH2CH3), 1.35 (9 H, s, (CH3)3C), 0.96 (3 H, t,
J = 7.5 Hz, CH3CH2).
13C NMR (126 MHz, CDCl3, 20 °C,
acquired in J-MOD pulse sequence): δ = 173.6, 169.6, 166.6
(CvO), 79.1 (C-5), 77.8 (C-2), 74.3 (CHOAc), 66.0 (CH2O), 51.5
(C(CH3)3), 36.1 (CH2CO), 28.7 ((CH3)3C), 27.5, 27.1 (C-3, C-4),
21.0 (CH3CO), 18.5 (CH3CH2), 13.8 (CH3CH2). I.r.: νmax 2966,
2939, 1736, 1678, 1529, 1456, 1366, 1221, 1178, 1081, 1047,
999, 959, 947, 920, 887, 798 cm−1. HRMS (ESI+): found
344.2059 [calcd for C17H30NO6
+ (M + H)+ 344.2068].
Syn-7a (minor). Oil. Rf = 0.55 (CH2Cl2/PE/EtOAc 3 : 2 : 2).
[α]D = +10.4 (c 0.53, CHCl3).
1H NMR (300 MHz, CDCl3, 20 °C):
δ = 5.85 (1 H, br s, NH), 5.00 (1 H, d, J = 4.3 Hz, CHOAc), 4.34
(1 H, td, J = 6.8, 4.2 Hz, 5-H), 4.20–4.05 (2 H, m, 2-H, CHHO),
4.09 (1 H, dd, J = 11.5, 4.0 Hz, CHHO), 2.32 (2 H, t, J = 7.4 Hz,
COCH2CH2CH3), 2.18 (3 H, s, CH3CO), 2.10–1.93 (2 H, m, 3-H,
4-H), 1.90–1.54 (4 H, m, 3-H, 4-H and COCH2CH2CH3), 1.35 (9
H, s, (CH3)3C), 0.96 (3 H, t, J = 7.4 Hz, CH3CH2).
13C NMR
(75 MHz, CDCl3, 20 °C): δ = 173.5, 169.7, 166.8 (CvO), 78.7
(C-2 or C-5), 77.3 (C-2 or C-5), 75.2 (CHOAc), 66.0 (CH2O), 51.4
(C(CH3)3), 36.1 (CH2CO), 28.6 ((CH3)3C), 28.0, 27.1 (C-3, C-4),
20.9 (CH3CO), 18.4 (CH3CH2), 13.7 (CH3CH2). I.r.: νmax 3366,
2967, 2877, 1735, 1671, 1528, 1455, 1393, 1366, 1218, 1176,
1079, 1044, 997, 932, 799, 753 cm−1. HRMS (ESI+): found
344.2062 [calcd for C17H30NO6
+ (M + H)+ 344.2068].
((2R,5S)-5-((S)-1-Acetoxy-2-((4-(benzyloxy)phenethyl)amino)-
2-oxoethyl)tetrahydrofuran-2-yl)methyl butyrate anti-7b and
((2R,5S)-5-((R)-1-acetoxy-2-((4-(benzyloxy)phenethyl)amino)-2-
oxoethyl)tetrahydrofuran-2-yl)methyl butyrate syn-7b. They
were prepared with the general procedures A, B or C, using iso-
cyanide 14.51 In the case of procedure B, the % of side pro-
ducts anti and syn-15b was determined by HPLC-MS-UV. Rt:
16.97 min (15b, 1 diast), 17.16 min (15b, 1 diast.), 17.79 min
(both anti and syn-7b). The dr was determined by 1H NMR on
the crude product. In the case of procedures A and C, no 15b
was detected. Pure anti-7b was best isolated from reaction
under condition C. In order to obtain a sample of syn-7b, a
chromatography (PE/EtOAc 1 : 1, then PE/Et2O 1 : 6) was per-
formed on the crude product obtained through procedure A,
followed by a preparative tlc. In this way we obtained syn-7b,
still contaminated by 13% of anti-7a.
Anti-7b (major). White solid. M.p. = 96.5–97.8 °C. Rf = 0.32
(PE/EtOAc 1 : 1). [α]D = +13.4 (c 1.1, CHCl3).
1H NMR (300 MHz,
CDCl3, 20 °C): δ = 7.46–7.28 (5 H, m, aromatics of Bn), 7.10
(2 H, d, J = 8.6 Hz, H meta to OBn), 6.92 (2 H, d, J = 8.6 Hz,
H ortho to OBn), 6.24 (1 H, br t, J = 5.5 Hz, NH), 5.15 (1 H, d, J =
4.8 Hz, CHOAc), 5.05 (2 H, s, CH2Ph), 4.28 (1 H, td, J = 6.8, 4.8
Hz, 5-H), 4.20–4.11 (1 H, m, 2-H), 4.03 and 4.00 (2 H, AB part
of an ABX syst., JAB = 11.5, JAX, JBX = 3.7, 6.6 Hz, CH2O), 3.57
(1 H, dq, J = 13.3, 6.6 Hz, NHCHH), 3.42 (1 H, dq, J = 13.3,
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7.0 Hz, NHCHH), 2.75 (2 H, t, J = 6.9 Hz, CH2Ar), 2.29 (2 H, t,
J = 7.4 Hz, CH2CO), 2.08 (3 H, s, CH3CO), 2.03–1.91 (3 H, m,
3-H, 4-H), 1.72–1.57 (3 H, m, CH3CH2, 3-H or 4-H), 0.94 (3 H, t,
J = 7.4 Hz, CH3CH2).
13C NMR (75 MHz, CDCl3, 20 °C): δ =
173.5, 169.4, 167.3 (CvO), 157.5, 137.0, 130.9 (quat.), 129.8
(CH meta to OBn), 128.6 (×2), 127.9, 127.4 (×2) (CH of Bn),
115.0 (CH ortho to OBn), 78.9 (C-5), 77.7 (C-2), 74.3 (CHOAc),
70.0 (OCH2Ph), 65.8 (CH2O), 40.5 (NCH2), 36.0 (CH2CO), 34.7
(CH2Ar), 27.5, 26.9 (C-3, C-4), 20.8 (CH3CO), 18.4 (CH3CH2),
13.6 (CH3CH2). I.r.: νmax 3300, 3077, 2963, 2924, 2876, 1741,
1728, 1659, 1613, 1582, 1556, 1515, 1451, 1418, 1386, 1369,
1332, 1300, 1271, 1238, 1191, 1181, 1119, 1079, 1019, 994, 942,
911, 885, 864, 835, 810, 793, 739, 698, 673, 662, 638, 619 cm−1.
HRMS (ESI+): found 498.2493 [calcd for C28H36NO7
+ (M + H)+
498.2492].
Syn-7b (minor). Oil. Rf = 0.22 (PE/EtOAc 1 : 1).
1H NMR
(300 MHz, CDCl3, 20 °C): δ = 7.46–7.31 (5 H, m, aromatics of
Bn), 7.11 (2 H, d, J = 8.4 Hz, H meta to OBn), 6.92 (2 H, d, J =
8.4 Hz, H ortho to OBn), 6.15 (1 H, br t, J = 5.6 Hz, NH), 5.11
(1 H, d, J = 3.8 Hz, CHOAc), 5.05 (2 H, s, CH2Ph), 4.36 (1 H, td,
J = 6.6, 4.9 Hz, 5-H), 4.20–4.07 (2 H, m, 2-H, CHHO), 4.04–3.95
(1 H, m, CHHO), 3.62–3.34 (2 H, m, NHCH2), 2.76 (2 H, t, J =
6.9 Hz, CH2Ar), 2.29 (2 H, t, J = 7.5 Hz, CH2CO), 2.07 (3 H, s,
CH3CO), 2.05–1.90 (3 H, m, 3-H, 4-H), 1.85–1.75 (1 H, m, 3-H
or 4-H), 1.64 (2 H, sextuplet, J = 7.5 Hz, CH2CH3), 0.93 (3 H, t,
J = 7.5 Hz, CH3CH2).
13C NMR (75 MHz, CDCl3, 20 °C): δ =
173.6, 169.5, 167.7 (CvO), 157.5, 137.0, 131.0 (quat.), 129.8
(CH meta to OBn), 128.6 (×2), 127.9, 127.4 (×2) (CH of Bn),
115.0 (CH ortho to OBn), 78.6 (C-5), 77.4 (C-2), 74.9 (CHOAc),
70.0 (OCH2Ph), 65.9 (CH2O), 40.5 (NCH2), 36.1 (CH2CO), 34.6
(CH2Ar), 28.0, 27.2 (C-3, C-4), 20.8 (CH3CO), 18.4 (CH3CH2),
13.7 (CH3CH2). I.r.: νmax 3300, 3077, 2963, 2924, 2876, 1741,
1728, 1659, 1613, 1582, 1556, 1515, 1451, 1418, 1386, 1369,
1332, 1300, 1271, 1238, 1191, 1181, 1119, 1079, 1019, 994, 942,
911, 885, 864, 835, 810, 793, 739, 698, 673, 662, 638, 619 cm−1.
HRMS (ESI+): found 498.2488 [calcd for C28H36NO7
+ (M + H)+
498.2492].
(S)-2-(Butylamino)-1-((2S,5R)-5-((butyryloxy)methyl)tetra-
hydrofuran-2-yl)-2-oxoethyl benzoate anti-7c and (R)-2-(butyl-
amino)-1-((2S,5R)-5-((butyryloxy)methyl)tetrahydrofuran-2-yl)-
2-oxoethyl benzoate syn-7c. They were prepared with the
general procedures A, B or C. The diastereomeric ratio was
determined by 1H NMR of the crude product. No 15c was
detected by HPLC-MS-UV or 1H NMR of the crude when the
reaction was carried out under conditions A and C. In order to
obtain the major diastereomer in pure form, two chromatogra-
phies (PE/Et2O 1 : 1) were performed. We also obtained some
mixed fractions, that afforded, upon further chromatography
with PE/Et2O 1 : 1, compound syn 7c, still containing a small
amount (about 10%) of the anti isomer.
Anti-7c (major). White solid. M.p. = 101.5–102.8 °C. Rf =
0.59 (PE/Et2O 1 : 3). [α]D = +6.1 (c 1.1, CHCl3).
1H NMR
(300 MHz, CDCl3, 20 °C): δ = 8.11–8.06 (2 H, m, H ortho to CO),
7.61 (1 H, tt, J = 7.5, 1.2 Hz, H para to CO), 7.48 (2 H, t, J = 7.5
Hz, H meta to CO), 6.30 (1 H, br t, J = 6.2 Hz, NH), 5.44 (1 H, d,
J = 5.0 Hz, CHOBz), 4.49 (1 H, td, J = 6.8, 5.0 Hz, 2-H), 4.20 (1 H,
qd, J = 7.0, 3.8 Hz, 5-H), 4.10 and 4.01 (2 H, AB part of an
ABX syst., JAB = 11.6, JAX, JBX = 3.7, 6.3 Hz, CH2O), 3.29 (2 H, br
q, J = 6.9 Hz, CH2NH), 2.23 (2 H, t, J = 7.4 Hz, CH2CO), 2.11
(2 H, q, J = 7.2 Hz, 3-H), 2.07–1.94 (1 H, m, 4-H), 1.80–1.68
(1 H, m, 4-H), 1.61 (2 H, hexuplet, J = 7.4 Hz, CH2CH2CO),
1.53–1.42 (2 H, m, NHCH2CH2CH2), 1.40–1.26 (2 H, m,
NHCH2CH2CH2), 0.92 (3 H, t, J = 7.4 Hz, CH3CH2), 0.91 (3 H, t,
J = 7.4 Hz, CH3CH2).
13C NMR (75 MHz, CDCl3, 20 °C): δ =
173.5, 167.4, 165.2 (CvO), 133.6, 129.8 (×2), 128.6 (×2) (aro-
matic CH), 129.3 (quat.), 78.9 (C-2), 77.9 (C-5), 74.8 (CHOBz),
65.8 (CH2O), 39.1 (NCH2), 36.0 (CH2CO), 31.5 (NHCH2CH2),
27.5 (C-4), 27.1 (C-3), 20.0, 18.4 (CH2), 13.7, 13.6 (CH3CH2).
I.r.: νmax 3674, 3296, 3078, 2959, 2913, 2871, 1741, 1724, 1655,
1603, 1561, 1451, 1392, 1373, 1302, 1263, 1246, 1174, 1124,
1101, 1070, 1026, 992, 942, 921, 902, 891, 825, 803, 766, 744,
706, 676, 635 cm−1. HRMS (ESI+): found 406.2231 [calcd for
C22H32NO6
+ (M + H)+ 406.2230].
Syn-7c (minor). Foam. Rf = 0.50 (PE/Et2O 1 : 3).
1H NMR
(300 MHz, CDCl3, 20 °C): δ = 8.16–8.09 (2 H, m, H ortho to CO),
7.64 (1 H, tt, J = 7.5, 2.1 Hz, H para to CO), 7.54–7.47 (2 H, m,
H meta to CO), 6.19 (1 H, br t, J = 5.1 Hz, NH), 5.44 (1 H, d, J =
3.3 Hz, CHOBz), 4.57 (1 H, td, J = 6.8, 3.3 Hz, 2-H), 4.25–4.15
(1 H, m, 5-H), 4.26, 4.05 (2 H, AB part of an ABX syst., JAB =
10.7, JAX, JBX = 3.4, 6.6 Hz, CH2O), 3.36–3.20 (2 H, m, CH2NH),
2.27 (2 H, t, J = 7.5 Hz, CH2CO), 2.15–1.85 (3 H, m, 3-H, 4-H),
1.67–1.55 (1 H, m, 4-H), 1.63 (2 H, hexuplet, J = 7.4 Hz,
CH2CH2CO), 1.53–1.42 (2 H, m, NHCH2CH2CH2), 1.40–1.26
(2 H, m, NHCH2CH2CH2), 0.92 (3 H, t, J = 7.4 Hz, CH3CH2),
0.89 (3 H, t, J = 7.4 Hz, CH3CH2).
13C NMR (75 MHz, CDCl3,
20 °C): δ = 173.6, 167.9, 165.3 (CvO), 133.8, 129.9 (×2), 128.8
(×2) (aromatic CH), 129.1 (quat.), 78.8, 77.2 (C-2 and C-5), 75.2
(CHOBz), 66.1 (CH2O), 39.1 (NCH2), 36.1 (CH2CO), 31.5
(NHCH2CH2), 28.1 (C-4), 27.3 (C-3), 20.0, 18.4 (CH2), 13.7, 13.6
(CH3CH2). I.r.: νmax 3674, 3296, 3078, 2959, 2913, 2871, 1741,
1724, 1655, 1603, 1561, 1451, 1392, 1373, 1302, 1263, 1246,
1174, 1124, 1101, 1070, 1026, 992, 942, 921, 902, 891, 825, 803,
766, 744, 706, 676, 635 cm−1. HRMS (ESI+): found 406.2225
[calcd for C22H32NO6
+ (M + H)+ 406.2230].
((2R,5S)-5-((S)-1-Acetoxy-2-(benzylamino)-2-oxoethyl)tetra-
hydrofuran-2-yl)methyl butyrate anti-7d. It was prepared with
the general procedures B or C. The diastereomeric ratio was
determined by 1H NMR of the crude product. No 15d was
detected by HPLC-MS-UV or 1H NMR of the crude when the
reaction was carried out under conditions C. In order to obtain
the major (anti) isomer in pure form (from procedure C), two
chromatographies (PE/Et2O 2 : 5) were performed. We have
also isolated a small amount of mixed fractions of syn and anti
compounds. Due to the proximity of the two spots, we failed to
obtain pure syn compound even through preparative tlc.
Therefore, the reported 1H NMR of the syn isomer was extrapo-
lated from the spectrum of an enriched 57 : 43 syn : anti
mixture.
Anti-7d (major). Foam. Rf = 0.37 (PE/EtOAc 1 : 1). [α]D = +4.1
(c 1.0, CHCl3).
1H NMR (300 MHz, CDCl3, 20 °C): 7.37–7.24
(5 H, m, aromatics of Bn), 6.60 (1 H, br t, J = 5.8 Hz, NH), 5.18
(1 H, d, J = 5.5 Hz, CHOAc), 4.52, 4.46 (2 H, AB part of an ABX
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syst., JAB = 15.0, JAX, JBX = 7.0, 6.2 Hz, CH2Ph), 4.50–4.42 (1 H,
m, 5-H), 4.25–4.10 (1 H, m, 2-H), 4.05 and 4.04 (2 H, AB part of
an ABX syst., JAB = 11.5, JAX, JBX = 2.6, 7.2 Hz, CH2O), 2.23 (2 H,
t, J = 7.5 Hz, CH2CO), 2.16 (3 H, s, CH3CO), 2.10–1.92 (3 H, m,
3-H, 4-H), 1.76–1.63 (1 H, m, 3-H or 4-H), 1.60 (2 H, hexuplet,
J = 7.5 Hz, CH2CH2CO), 0.91 (3 H, t, J = 7.4 Hz, CH3CH2).
13C
NMR (75 MHz, CDCl3, 20 °C): δ = 173.3, 169.4, 167.5 (CvO),
138.1 (quat.), 128.7 (×2), 127.6 (×2), 127.5 (aromatic CH), 78.9
(C-5), 78.0 (C-2), 74.6 (CHOAc), 65.8 (CH2O), 43.3 (NCH2), 36.0
(CH2CO), 27.5, 27.3 (C-3, C-4), 20.7 (CH3CO), 18.3 (CH3CH2),
13.5 (CH3CH2). I.r.: νmax 3274, 3093, 3036, 2966, 2920, 2873,
1736, 1665, 1652, 1589, 1565, 1538, 1497, 1454, 1417, 1395,
1371, 1334, 1309, 1274, 1235, 1175, 1118, 1076, 1040, 1029,
1008, 992, 957, 937, 912, 884, 835, 789, 770, 745, 694, 648,
610 cm−1. HRMS (ESI+): found 378.1915 [calcd for C20H28NO6
+
(M + H)+ 378.1917].
Syn-7d (minor). Foam. Rf = 0.32 (PE/EtOAc 1 : 1).
1H NMR
(300 MHz, CDCl3, 20 °C): 7.37–7.23 (5 H, m, aromatics of Bn),
6.50 (1 H, br t, J = 5.1 Hz, NH), 5.21 (1 H, d, J = 3.6 Hz,
CHOAc), 4.52 and 4.46 (2 H, AB part of an ABX syst., JAB = 15.0,
JAX, JBX = 7.0, 6.2 Hz, CH2Ph), 4.50–4.40 (1 H, m, 5-H),
4.25–4.10 (1 H, m, 2-H and CHHO), 4.05–3.94 (1 H, m, CHHO),
2.24 (2 H, t, J = 7.5 Hz, CH2CO), 2.18 (3 H, s, CH3CO),
2.10–1.92 (3 H, m, 3-H, 4-H), 1.76–1.63 (1 H, m, 3-H or 4-H),
1.61 (2 H, hexuplet, J = 7.5 Hz, CH2CH2CO), 0.91 (3 H, t, J = 7.4
Hz, CH3CH2).
((2R,5S)-5-((S)-1-Acetoxy-2-((4-(allyloxy)phenyl)amino)-2-oxoethyl)
tetrahydrofuran-2-yl)methyl butyrate anti-7e. It was prepared with
the general procedures B or C, using 4-(allyloxyphenyl)isocya-
nide.52 The diastereomeric ratio was determined by 1H NMR of
the crude product. No 15e was detected in this NMR when the
reaction was carried out under conditions C. In order to obtain
the major (anti) isomer in pure form (from procedure C), two
chromatographies (PE/EtOAc 2 : 1, then PE/Et2O 1 : 4) were per-
formed on the crude derived from procedure C. We have also
isolated a small amount of mixed fractions of syn and anti
compounds. Due to the proximity of the two spots, we failed to
obtain pure syn compound even through preparative tlc.
Therefore, the reported 1H and 13C NMR of the syn isomer was
extrapolated from the spectrum of an enriched 41 : 59 syn : anti
mixture.
Anti-7e (major). White solid. M.p. = 105.0–107.5 °C. Rf =
0.64 (CH2Cl2/PE/EtOAc 3 : 2 : 2). [α]D = −13.1 (c 0.57, CHCl3). 1H
NMR (300 MHz, CDCl3, 20 °C): δ = 8.02 (1 H, s, NH), 7.43 (2 H,
d, J = 9.0 Hz, H meta to OAll), 6.87 (2 H, d, J = 9.0 Hz, H ortho
to OAll), 6.04 (1 H, tdd, J = 5.3, 10.5, 17.3 Hz, CHvCH2), 5.40
(1 H, dq, J = 17.3, 1.6 Hz, CHvCHH), 5.28 (1 H, dq, J = 10.5,
1.4 Hz, CHvCHH), 5.18 (1 H, d, J = 5.8 Hz, CHOAc), 4.53 (2 H,
dt, J = 5.3, 1.5 Hz, CH2CHvCH2), 4.36 (1 H, q, J = 6.6 Hz, 5-H),
4.30–4.20 (1 H, m, 2-H), 4.16 and 4.11 (2 H, AB part of an ABX
syst., JAB = 11.7, JAX, JBX = 3.4, 6.2 Hz, CH2O), 2.25 (2 H, t, J =
7.4 Hz, CH2CO), 2.21 (3 H, s, CH3CO), 2.15–1.94 (3 H, m, 3-H,
4-H), 1.82–1.69 (1 H, m, 3-H or 4-H), 1.67–1.53 (2 H, m,
CH2CH3), 0.91 (3 H, t, J = 7.4 Hz, CH3CH2).
13C NMR (75 MHz,
CDCl3, 20 °C): δ = 173.6, 169.6, 165.3 (CvO), 155.5, 130.6
(quat.), 133.2 (CHvCH2), 121.6 (CH meta to OAll), 117.7
(CHvCH2), 115.0 (CH ortho to OAll), 78.8 (C-5), 78.2 (C-2),
74.8 (CHOAc), 69.1 (OCH2CHv), 65.7 (CH2O), 36.0 (CH2CO),
27.8, 27.2 (C-3, C-4), 20.9 (CH3CO), 18.4 (CH3CH2), 13.6
(CH3CH2). I.r.: νmax 3275, 3137, 3073, 2965, 2923, 2874, 1744,
1735, 1673, 1650, 1602, 1543, 1515, 1456, 1416, 1408, 1394,
1372, 1304, 1286, 1252, 1231, 1190, 1175, 1106, 1080, 1037,
996, 947, 918, 885, 832, 809, 778, 739, 716, 689, 651, 635 cm−1.
HRMS (ESI+): found 420.2020 [calcd for C22H30NO7
+ (M + H)+
420.2022].
Syn-7e (minor). Foam. Rf = 0.62 (CH2Cl2/PE/EtOAc 3 : 2 : 2).
1H NMR (300 MHz, CDCl3, 20 °C): δ = 7.84 (1 H, s, NH), 7.47
(2 H, d, J = 9.0 Hz, H meta to OAll), 6.87 (2 H, d, J = 9.0 Hz,
H ortho to OAll), 6.04 (1 H, tdd, J = 5.3, 10.5, 17.3 Hz, CHvCH2),
5.40 (1 H, dq, J = 17.3, 1.6 Hz, CHvCHH), 5.28 (1 H, dq, J =
10.5, 1.4 Hz, CHvCHH), 5.25 (1 H, d, J = 3.6 Hz, CHOAc), 4.53
(2 H, dt, J = 5.3, 1.5 Hz, CH2CHvCH2), 4.44 (1 H, td, J = 6.3,
3.6 Hz, 5-H), 4.32 (1 H, dd, J = 11.3, 7.2 Hz, CHHO), 4.30–4.20
(1 H, m, 2-H), 4.02 (1 H, dd, J = 11.3, 3.6 Hz, CHHO), 2.25 (2 H,
t, J = 7.4 Hz, CH2CO), 2.24 (3 H, s, CH3CO), 2.15–1.94 (3 H, m,
3-H, 4-H), 1.82–1.69 (1 H, m, 3-H or 4-H), 1.67–1.53 (2 H, m,
CH2CH3), 0.91 (3 H, t, J = 7.4 Hz, CH3CH2).
13C NMR (75 MHz,
CDCl3, 20 °C): δ = 173.7, 169.6, 165.7 (CvO), 155.5, 130.5
(quat.), 133.2 (CHvCH2), 121.8 (CH meta to OAll), 117.7
(CHvCH2), 115.0 (CH ortho to OAll), 78.8 (C-5), 77.8 (C-2),
74.8 (CHOAc), 69.1 (OCH2CHv), 65.8 (CH2O), 36.1 (CH2CO),
27.7, 27.3 (C-3, C-4), 20.9 (CH3CO), 18.4 (CH3CH2), 13.6
(CH3CH2).
(S)-1-((2S,5R)-5-((Butyryloxy)methyl)tetrahydrofuran-2-yl)-2-
(methylamino)-2-oxoethyl benzoate anti-7f. It was prepared
with the general procedure C. The diastereomeric ratio was
determined by 1H NMR of the crude product. No 15f was
detected in this NMR. In order to obtain the major (anti)
isomer in pure form (from procedure C), two chromatogra-
phies (PE/EtOAc 2 : 3 and then PE/Et2O 1 : 5) were performed
on the crude derived from procedure C. We have also isolated
a small amount of mixed fractions of syn and anti compounds.
Due to the proximity of the two spots, we failed to obtain pure
syn compound even through preparative tlc. Therefore, the
reported 1H NMR spectrum was extrapolated from the spec-
trum of an enriched 50 : 50 syn : anti mixture.
Anti-7f. Yellowish solid. M.p. = 87.8–89.9 °C. Rf = 0.34 (PE/
Et2O 1 : 5). [α]D = +7.8 (c 1.0, CHCl3).
1H NMR (300 MHz,
CDCl3, 20 °C): δ = 8.12–8.06 (2 H, m, H ortho to CO), 7.61 (1 H,
tt, J = 7.4, 1.3 Hz, H para to CO), 7.47 (2 H, t, J = 7.6 Hz, H meta
to CO), 6.33 (1 H, br s, NH), 5.45 (1 H, d, J = 4.8 Hz, CHOBz),
4.49 (1 H, td, J = 6.8, 4.9 Hz, 2-H), 4.20 (1 H, qd, J = 6.6, 3.9 Hz,
5-H), 4.08 and 4.03 (2 H, AB part of an ABX syst., JAB = 11.5,
JAX, JBX = 3.6, 6.4 Hz, CH2O), 2.85 (3 H, d, J = 4.9 Hz, CH3NH),
2.23 (2 H, t, J = 7.5 Hz, CH2CO), 2.18–1.94 (3 H, m, 3-H, 4-H),
1.82–1.66 (1 H, m, 4-H), 1.61 (2 H, hexuplet, J = 7.4 Hz,
CH2CH2CO), 0.92 (3 H, t, J = 7.5 Hz, CH3CH2).
13C NMR
(75 MHz, CDCl3, 20 °C): δ = 173.6, 168.1, 165.2 (CvO), 133.6,
129.9 (×2), 128.6 (×2) (aromatic CH), 129.3 (quat.), 78.9 (C-2),
77.9 (C-5), 74.9 (CHOBz), 65.8 (CH2O), 36.0 (CH2CO), 27.5
(C-4), 27.1 (C-3), 26.1 (CH3NH), 18.4 (CH2), 13.6 (CH3CH2). I.r.:
νmax 3676, 3294, 3098, 2956, 2932, 2877, 1718, 1662, 1603,
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1559, 1467, 1451, 1418, 1401, 1385, 1367, 1352, 1308, 1295,
1256, 1200, 1190, 1178, 1165, 1136, 1125, 1098, 1078, 1071,
1046, 1026, 1016, 1009, 986, 965, 950, 937, 914, 891, 848, 835,
806, 777, 734, 707, 694, 686, 677, 632 cm−1. HRMS (ESI+):
found 364.1755 [calcd for C19H26NO6
+ (M + H)+ 364.1760].
Syn-7f. Foam. Rf = 0.33 (PE/Et2O 1 : 5).
1H NMR (300 MHz,
CDCl3, 20 °C): δ = 8.14 (2 H, d, J = 8.1 Hz, H ortho to CO), 7.63
(1 H, t, J = 7.4 Hz, H para to CO), 7.50 (2 H, t, J = 7.6 Hz,
H meta to CO), 6.29 (1 H, br s, NH), 5.47 (1 H, d, J = 3.3 Hz,
CHOBz), 4.57 (1 H, td, J = 6.6, 3.3 Hz, 2-H), 4.32 (1 H, dd, J =
11.1, 6.9 Hz, CHHO), 4.10–3.98 (2 H, m, 5-H, CHHO), 2.84
(3 H, d, J = 4.9 Hz, CH3NH), 2.28 (2 H, t, J = 7.5 Hz, CH2CO),
2.18–1.94 (3 H, m, 3-H, 4-H), 1.82–1.66 (1 H, m, 4-H), 1.61
(2 H, hexuplet, J = 7.4 Hz, CH2CH2CO), 0.92 (3 H, t, J = 7.5 Hz,
CH3CH2).
(S)-2-(2-(4-Benzyloxyphenyl)ethylamino)-1-((2S,5R)-5-((butyryloxy)
methyl)tetrahydrofuran-2-yl)-2-oxoethyl benzoate anti-7g and
(R)-2-(2-(4-benzyloxyphenyl)ethylamino)-1-((2S,5R)-5-((butyryl-
oxy)methyl)tetrahydrofuran-2-yl)-2-oxoethyl benzoate syn-7g.
They were prepared with the general procedure C, using isocya-
nide 14.51 The diastereomeric ratio was determined by 1H
NMR of the crude product. No 15g was detected in this NMR.
In order to obtain the two diastereomers in pure form, two
chromatographies (PE/Et2O 1 : 2) were performed.
Anti-7g. White solid. M.p. = 107.0–108.2 °C. Rf = 0.53 (PE/
Et2O 1 : 3). [α]D = +3.0 (c 1.0, CHCl3).
1H NMR (300 MHz,
CDCl3, 20 °C): δ = 8.03–7.98 (2 H, m, H ortho to CO), 7.59 (1 H,
tt, J = 7.5, 1.3 Hz, H para to CO), 7.46 (2 H, t, J = 7.6 Hz, H meta
to CO), 7.43–7.28 (5 H, m, CH of benzyl), 7.07 (2 H, d, J = 8.7
Hz, H meta to OBn), 6.81 (2 H, d, J = 8.7 Hz, H ortho to OBn),
6.30 (1 H, br t, J = 5.7 Hz, NH), 5.47 (1 H, d, J = 4.4 Hz,
CHOBz), 4.97 (2 H, s, CH2Ph), 4.46 (1 H, td, J = 6.9, 4.5 Hz,
2-H), 4.15 (1 H, qd, J = 6.4, 3.9 Hz, 5-H), 4.04 and 3.95 (2 H, AB
part of an ABX syst., JAB = 11.5, JAX, JBX = 4.0, 6.2 Hz, CH2O),
3.64–3.40 (2 H, m, CH2NH), 2.75 (2 H, t, J = 7.0, CH2Ar), 2.18 (2
H, t, J = 7.4 Hz, CH2CO), 2.14–1.91 (3 H, m, 3-H, 4-H),
1.88–1.74 (1 H, m, 4-H), 1.58 (2 H, hexuplet, J = 7.4 Hz,
CH2CH2CO), 0.89 (3 H, t, J = 7.4 Hz, CH3CH2).
13C NMR
(75 MHz, CDCl3, 20 °C): δ = 173.5, 167.3, 165.0 (CvO), 157.5,
137.0, 130.8, 129.2 (quat.), 133.6 (CH meta to CO), 129.83 (×2),
129.75 (×2), 128.6 (×3), 128.0, 127.4 (×2) (other aromatic CH),
115.0 (CH ortho to OBn), 79.0 (C-2), 77.8 (C-5), 74.8 (CHOBz),
70.0 (CH2Ph), 65.7 (CH2O), 40.4 (CH2NH), 36.9 (CH2CO), 34.7
(CH2Ar), 27.6 (C-4), 26.9 (C-3), 18.3 (CH2), 13.6 (CH3CH2). I.r.:
νmax 3676, 3305, 3096, 3066, 3036, 2967, 2944, 2921, 2872,
1735, 1725, 1686, 1655, 1611, 1557, 1511, 1470, 1453, 1419,
1393, 1380, 1359, 1298, 1284, 1259, 1241, 1200, 1173, 1129,
1114, 1097, 1080, 1067, 1052, 1025, 1013, 997, 927, 910, 888,
866, 836, 814, 785, 749, 728, 709, 702, 684, 663, 636, 617 cm−1.
HRMS (ESI+): found 560.2653 [calcd for C33H38NO7
+ (M + H)+
560.2648].
Syn-7g. Foam. Rf = 0.44 (PE/Et2O 1 : 3). [α]D = −20.0 (c 1.0,
CHCl3).
1H NMR (300 MHz, CDCl3, 20 °C): δ = 8.01 (2 H, d, J =
7.2 Hz, H ortho to CO), 7.60 (1 H, t, J = 7.4 Hz, H para to CO),
7.47 (2 H, t, J = 7.8 Hz, H meta to CO), 7.43–7.28 (5 H, m, CH of
benzyl), 7.06 (2 H, d, J = 8.4 Hz, H meta to OBn), 6.78 (2 H, d,
J = 8.4 Hz, H ortho to OBn), 6.22 (1 H, br t, J = 5.7 Hz, NH), 5.45
(1 H, d, J = 3.1 Hz, CHOBz), 4.95 (2 H, s, CH2Ph), 4.56 (1 H, td,
J = 6.6, 3.1 Hz, 2-H), 4.25–4.12 (2 H, m, 5-H, CHHO), 4.04 (1 H,
dd, J = 13.8, 6.9 Hz, CHHO), 3.51 (2 H, q, J = 6.5 Hz, CH2NH),
2.74 (2 H, t, J = 6.7 Hz, CH2Ar), 2.23 (2 H, t, J = 7.4 Hz, CH2CO),
2.14–1.80 (4 H, m, 3-H, 4-H), 1.60 (2 H, hexuplet, J = 7.4 Hz,
CH2CH2CO), 0.89 (3 H, t, J = 7.4 Hz, CH3CH2).
13C NMR
(75 MHz, CDCl3, 20 °C): δ = 173.5, 167.8, 165.1 (CvO), 157.5,
137.0, 130.9, 128.9 (quat.), 133.7 (CH meta to CO), 129.8 (×3),
128.7 (×2), 128.6 (×2), 127.9, 127.4 (×2) (other aromatic CH),
114.9 (CH ortho to OBn), 78.8 (C-2), 77.4 (C-5), 74.9 (CHOBz),
69.9 (CH2Ph), 66.1 (CH2O), 40.4 (CH2NH), 36.0 (CH2CO), 34.6
(CH2Ar), 28.1 (C-4), 27.2 (C-3), 18.4 (CH2), 13.6 (CH3CH2). I.r.:
νmax 3676, 3305, 3096, 3066, 3036, 2967, 2944, 2921, 2872,
1735, 1725, 1686, 1655, 1611, 1557, 1511, 1470, 1453, 1419,
1393, 1380, 1359, 1298, 1284, 1259, 1241, 1200, 1173, 1129,
1114, 1097, 1080, 1067, 1052, 1025, 1013, 997, 927, 910, 888,
866, 836, 814, 785, 749, 728, 709, 702, 684, 663, 636, 617 cm−1.
HRMS (ESI+): found 560.2657 [calcd for C33H38NO7






7h. They were prepared with the general procedure C. The dia-
stereomeric ratio was determined by 1H NMR of the crude
product. No 15h was detected in this NMR. In order to obtain
the two diastereomers in pure form, two chromatographies
(PE/Et2O 2 : 3) were performed.
Anti-7h (major). White solid. M.p. = 85.9–87.3 °C. Rf = 0.66
(PE/Et2O 1 : 3). [α]D = −9.7 (c 1.0, CHCl3). 1H NMR (300 MHz,
CDCl3, 20 °C): δ = 7.33–7.17 (5 H, m, aromatics), 6.01 (1 H, d,
J = 8.2 Hz, NH), 5.12 (1 H, d, J = 5.2 Hz, CHOCO), 4.32–4.24 (1 H,
m, 2-H), 4.22–4.10 (1 H, m, 5-H), 4.10 and 4.02 (2 H, AB part of
an ABX syst., JAB = 11.4, JAX, JBX = 3.7, 6.5 Hz, CH2O), 3.80–3.65
(1 H, m, CHNH), 3.00 (2 H, t, J = 7.5, CH2Ar), 2.77 (2 H, t, J =
7.5, CH2CO), 2.32 (2 H, t, J = 7.4 Hz, CH2CO), 2.03–1.75 (6 H,
m, 3-H, 4-H, 3 H of cyclohexyl), 1.75–1.53 (5 H, m, 4-H and 4 H
of cyclohexyl), 1.66 (2 H, hexuplet, J = 7.4 Hz, CH2CH2CO),
1.43–1.00 (3 H, m, CH2 of cyclohexyl), 0.95 (3 H, t, J = 7.4 Hz,
CH3CH2).
13C NMR (75 MHz, CDCl3, 20 °C): δ = 173.4, 171.4,
166.3, (CvO), 140.0 (quat.), 128.5 (×2), 128.2 (×2), 126.3 (aro-
matic CH), 78.8 (C-2), 77.7 (C-5), 74.2 (CHOCO), 65.8 (CH2O),
47.9 (CHNH), 35.9 (CH2CO butyryl), 35.5 (other CH2CO), 32.7,
32.6, 25.4, 24.62, 24.59 (CH2 of cyclohexyl), 30.6 (CH2Ar), 27.3
(C-4), 26.9 (C-3), 18.3 (CH2), 13.6 (CH3CH2). I.r.: νmax 3676,
3294, 3064, 3027, 2964, 2924, 2852, 1739, 1650, 1606, 1548,
1501, 1454, 1440, 1419, 1394, 1363, 1305, 1267, 1246, 1230,
1171, 1117, 1073, 1031, 995, 968, 950, 918, 886, 805, 784, 770,
749, 715, 695, 674, 630 cm−1. HRMS (ESI+): found 460.2702
[calcd for C26H38NO6
+ (M + H)+ 460.2699].
Syn-7h (minor). Oil. Rf = 0.42 (PE/Et2O 1 : 3). [α]D = +11.7
(c 0.73, CHCl3).
1H NMR (300 MHz, CDCl3, 20 °C): δ = 7.33–7.20
(5 H, m, aromatics), 5.83 (1 H, d, J = 8.4 Hz, NH), 5.10 (1 H, d,
J = 3.9 Hz, CHOCO), 4.34 (1 H, td, J = 6.6, 3.9 Hz, 2-H), 4.18–4.07
(2 H, m, 5-H, CHHO), 4.05–3.96 (1 H, m, CHHO), 3.80–3.65
Organic Chemistry Frontiers Research Article


















































(1 H, m, CHNH), 3.01 (2 H, t, J = 7.5, CH2Ar), 2.78 (2 H, t, J = 7.5,
CH2CO), 2.31 (2 H, t, J = 7.4 Hz, CH2CO), 2.05–1.75 (6 H, m,
3-H, 4-H, 3 H of cyclohexyl), 1.75–1.53 (5 H, m, 4-H and 4 H of
cyclohexyl), 1.66 (2 H, hexuplet, J = 7.5 Hz, CH2CH2CO),
1.43–1.00 (3 H, m, CH2 of cyclohexyl), 0.95 (3 H, t, J = 7.4 Hz,
CH3CH2).
13C NMR (75 MHz, CDCl3, 20 °C): δ = 173.5, 171.6,
166.8, (CvO), 140.0 (quat.), 128.6 (×2), 128.3 (×2), 126.5 (aro-
matic CH), 78.7 (C-2), 77.4 (C-5), 74.9 (CHOCO), 66.0 (CH2O),
48.1 (CHNH), 36.1 (CH2CO butyryl), 35.7 (other CH2CO), 32.82,
32.76, 25.5, 24.8 (×2) (CH2 of cyclohexyl), 30.7 (CH2Ar), 28.0
(C-4), 27.1 (C-3), 18.4 (CH2), 13.7 (CH3CH2). I.r.: νmax 3309,
3028, 2932, 2855, 1736, 1659, 1604, 1530, 1497, 1452, 1418,
1364, 1255, 1173, 1146, 1078, 1050, 997, 947, 891, 805, 785,
751, 699 cm−1. HRMS (ESI+): found 460.2704 [calcd for
C26H38NO6
+ (M + H)+ 460.2699].
(S)-1-((2S,5R)-5-((Butyryloxy)methyl)tetrahydrofuran-2-yl)-2-
(tert-butylamino)-2-oxoethyl 3-phenylpropionate anti-7i and
(R)-1-((2S,5R)-5-((butyryloxy)methyl)tetrahydrofuran-2-yl)-2-
(tert-butylamino)-2-oxoethyl 3-phenylpropionate syn-7i.
They were prepared with the general procedure C. The diaster-
eomeric ratio was determined by 1H NMR of the crude
product. No 15i was detected in this NMR. In order to obtain
the two diastereomers in pure form, two chromatographies
(PE/Et2O from 6 : 7 to 2 : 3) were performed.
Anti-7i. Oil. Rf = 0.34 (PE/Et2O 6 : 7). [α]D = −10.9 (c 1.0,
CHCl3).
1H NMR (300 MHz, CDCl3, 20 °C): δ = 7.33–7.17 (5 H,
m, aromatics), 5.99 (1 H, s, NH), 5.05 (1 H, d, J = 5.2 Hz,
CHOCO), 4.30–4.13 (2 H, m, 2-H, 5-H), 4.10 and 4.02 (2 H, AB
part of an ABX syst., JAB = 11.3, JAX, JBX = 4.1, 6.2 Hz, CH2O),
3.05–2.91 (2 H, m, CH2Ar), 2.80–2.71 (2 H, m, CH2CO), 2.32
(2 H, t, J = 7.5 Hz, CH2CO), 2.03–1.87 (3 H, m, 3-H, 4-H),
1.75–1.50 (1 H, m, 4-H), 1.66 (2 H, hexuplet, J = 7.45 Hz,
CH2CH2CO), 1.31 (9 H, s, (CH3)3C), 0.95 (3 H, t, J = 7.4 Hz,
CH3CH2).
13C NMR (75 MHz, CDCl3, 20 °C): δ = 173.3, 171.4,
166.4, (CvO), 140.1 (quat.), 128.5 (×2), 128.2 (×2), 126.3 (aro-
matic CH), 78.9 (C-2), 77.6 (C-5), 74.2 (CHOCO), 65.8 (CH2O),
47.9 (CHNH), 35.9 (CH2CO butyryl), 35.5 (other CH2CO), 51.2
(C(CH3)3), 35.9 (CH2CO of butyryl), 35.6 (other CH2CO), 30.6
(CH2Ar), 28.5 (C(CH3)3, 27.3 (C-4), 26.9 (C-3), 18.3 (CH2), 13.6
(CH3CH2). I.r.: νmax 3370, 3029, 2966, 2877, 1736, 1680, 1604,
1524, 1498, 1454, 1418, 1392, 1365, 1246, 1225, 1172, 1079,
1048, 999, 911, 888, 798, 732, 699, 646 cm−1. HRMS (ESI+):
found 434.2548 [calcd for C24H36NO6
+ (M + H)+ 434.2543].
Syn-7i. Oil. Rf = 0.22 (PE/Et2O 6 : 7). [α]D = +46.7 (c 0.32,
CHCl3).
1H NMR (300 MHz, CDCl3, 20 °C): δ = 7.33–7.17 (5 H,
m, aromatics), 5.76 (1 H, s, NH), 5.01 (1 H, d, J = 4.2 Hz,
CHOCO), 4.31 (1 H, td, J = 6.6, 4.2 Hz, 2-H), 4.15–3.95 (3 H, m,
5-H, CH2O), 3.05–2.91 (2 H, m, CH2Ar), 2.80–2.71 (2 H, m,
CH2CO), 2.30 (2 H, t, J = 7.5 Hz, CH2CO), 2.03–1.87 (3 H, m,
3-H, 4-H), 1.77–1.50 (1 H, m, 4-H), 1.66 (2 H, hexuplet, J = 7.5
Hz, CH2CH2CO), 1.30 (9 H, s, (CH3)3C), 0.95 (3 H, t, J = 7.4 Hz,
CH3CH2).
13C NMR (75 MHz, CDCl3, 20 °C): δ = 173.4, 171.6,
166.8, (CvO), 140.1 (quat.), 128.6 (×2), 128.3 (×2), 126.5 (aro-
matic CH), 78.7 (C-2), 77.3 (C-5), 75.2 (CHOCO), 66.0 (CH2O),
47.9 (CHNH), 35.9 (CH2CO butyryl), 35.5 (other CH2CO), 51.3
(C(CH3)3), 36.1 (CH2CO of butyryl), 35.8 (other CH2CO), 30.8
(CH2Ar), 28.6 (C(CH3)3, 28.0 (C-4), 27.1 (C-3), 18.4 (CH2),
13.7 (CH3CH2). I.r.: νmax 3370, 3029, 2966, 2877, 1736, 1680,
1604, 1524, 1498, 1454, 1418, 1392, 1365, 1246, 1225, 1172,
1079, 1048, 999, 911, 888, 798, 732, 699, 646 cm−1. HRMS
(ESI+): found 434.2545 [calcd for C24H36NO6






benzoate syn-7j. They were prepared with the general pro-
cedure C. The diastereomeric ratio was determined by 1H NMR
of the crude product. No 15j was detected in this NMR. In
order to obtain the two diastereoisomers in pure form, two
chromatographies (PE/Et2O 7 : 6) were performed.
Anti-7j. White solid. M.p. = 95.8–96.4 °C. Rf = 0.44 (PE/Et2O
1 : 1). [α]D = +16.6 (c 1.0, CHCl3).
1H NMR (300 MHz, CDCl3,
20 °C): δ = 8.02–7.97 (1 H, m, H ortho to CO), 7.64 (1 H, s, NH),
7.43 (1 H, td, J = 7.6, 1.2 Hz, H para to CO), 7.31–7.23 (2 H, m,
H meta to CO), 7.13–7.02 (3 H, m, CH of dimethylphenyl), 5.48
(1 H, d, J = 6.2 Hz, CHOCO), 4.55 (1 H, q, J = 6.6 Hz, 2-H),
4.32–4.24 (1 H, m, 5-H), 4.18 and 4.14 (2 H, AB part of an ABX
syst., JAB = 11.7, JAX, JBX = 3.6, 6.3 Hz, CH2O), 2.64 (3 H, s,
CH3Ar), 2.25 (6 H, s, CH3Ar), 2.23 (2 H, t, J = 7.5 Hz, CH2CO),
2.25–2.00 (3 H, m, 3-H, 4-H), 1.88–1.75 (1 H, m, 4-H), 1.58
(2 H, hexuplet, J = 7.4 Hz, CH2CH2CO), 0.88 (3 H, t, J = 7.4 Hz,
CH3CH2).
13C NMR (75 MHz, CDCl3, 20 °C): δ = 173.6, 166.2,
166.1 (CvO), 140.8, 135.4 (×2), 133.1, 128.6 (quat.), 132.5,
131.8, 130.6, 128.1 (×2), 127.3, 125.8 (aromatic CH), 78.8 (C-2),
78.1 (C-5), 74.8 (CHOCO), 65.7 (CH2O), 35.9 (CH2CO), 27.9
(C-4), 27.3 (C-3), 21.7, 18.5 (×2) (CH3Ar), 18.3 (CH2), 13.6
(CH3CH2). I.r.: νmax 3254, 3043, 2966, 2928, 2878, 1723, 1666,
1602, 1577, 1532, 1457, 1380, 1303, 1278, 1242, 1174, 1141,
1113, 1083, 1062, 996, 937, 915, 893, 851, 809, 794, 763, 732,
718, 695, 626 cm−1. HRMS (ESI+): found 468.2386 [calcd for
C27H34NO6
+ (M + H)+ 468.2386].
Syn-7j. Rf = 0.29 (PE/Et2O 1 : 1). [α]D = +21.3 (c 0.85, CHCl3).
1H NMR (300 MHz, CDCl3, 20 °C): δ = 8.07 (1 H, dd, J = 8.2, 1.3
Hz, H ortho to CO), 7.48 (1 H, td, J = 7.5, 1.2 Hz, H para to CO),
7.44 (1 H, s, NH), 7.35–7.28 (2 H, m, H meta to CO), 7.13–7.02
(3 H, m, CH of dimethylphenyl), 5.54 (1 H, d, J = 3.0 Hz,
CHOCO), 4.65 (1 H, td, J = 6.8, 3.0 Hz, 2-H), 4.30–4.17 (3 H, m,
5-H, CH2O), 2.67 (3 H, s, CH3Ar), 2.24 (2 H, t, J = 7.2 Hz,
CH2CO), 2.22 (6 H, s, CH3Ar), 2.25–1.97 (3 H, m, 3-H, 4-H),
1.88–1.73 (1 H, m, 4-H), 1.57 (2 H, hexuplet, J = 7.5 Hz,
CH2CH2CO), 0.88 (3 H, t, J = 7.4 Hz, CH3CH2).
13C NMR
(75 MHz, CDCl3, 20 °C): δ = 173.6, 166.8, 166.0 (CvO), 141.4,
135.5 (×2), 132.9, 128.0 (quat.), 133.0, 132.2, 130.5, 128.2 (×2),
127.4, 126.1 (aromatic CH), 78.7 (C-2), 78.6 (C-5), 75.6
(CHOCO), 66.1 (CH2O), 36.0 (CH2CO), 28.1 (C-4), 27.3 (C-3),
21.9, 18.4 (×2) (CH3Ar), 18.3 (CH2), 13.6 (CH3CH2). I.r.: νmax
3254, 3043, 2966, 2928, 2878, 1723, 1666, 1602, 1577, 1532,
1457, 1380, 1303, 1278, 1242, 1174, 1141, 1113, 1083, 1062,
996, 937, 915, 893, 851, 809, 794, 763, 732, 718, 695, 626 cm−1.
HRMS (ESI+): found 468.2394 [calcd for C27H34NO6
+ (M + H)+
468.2386].
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tetrahydrofuran-2-yl)-2-oxoethyl 2-methylbenzoate syn-7k. They
were prepared with the general procedure C. The diastereo-
meric ratio was determined by 1H NMR of the crude product.
No 15k was detected in this NMR. In order to obtain the two
diastereomers in pure form, two chromatographies (PE/Et2O
3 : 2) were performed.
Anti-7k. Oil. Rf = 0.47 (PE/Et2O 1 : 1). [α]D = +7.6 (c 1.5,
CHCl3).
1H NMR (300 MHz, CDCl3, 20 °C): δ = 7.98–7.93 (1 H,
m, H ortho to CO), 7.43 (1 H, td, J = 7.5, 1.4 Hz, H para to CO),
7.31–7.23 (2 H, m, H meta to CO), 6.13 (1 H, s, NH), 5.30 (1 H,
d, J = 5.1 Hz, CHOCO), 4.42 (1 H, td, J = 6.8, 5.2 Hz, 2-H),
4.25–4.14 (1 H, m, 5-H), 4.12 and 4.02 (2 H, AB part of an ABX
syst., JAB = 11.4, JAX, JBX = 3.8, 6.4 Hz, CH2O), 2.62 (3 H, s,
CH3Ar), 2.25 (2 H, t, J = 7.5 Hz, CH2CO), 2.13–1.93 (3 H, m,
3-H, 4-H), 1.79–1.65 (1 H, m, 4-H), 1.62 (2 H, hexuplet, J = 7.4
Hz, CH2CH2CO), 1.36 (9 H, s, C(CH3)3), 0.92 (3 H, t, J = 7.4 Hz,
CH3CH2).
13C NMR (75 MHz, CDCl3, 20 °C): δ = 173.4, 166.7,
165.9 (CvO), 140.7, 128.7 (quat.), 132.5, 131.8, 130.5, 125.9
(aromatic CH), 79.0 (C-2), 77.7 (C-5), 74.7 (CHOCO), 65.8
(CH2O), 51.4 (C(CH3)3), 35.9 (CH2CO), 28.7 (C(CH3)3), 27.4
(C-4), 27.1 (C-3), 21.8 (CH3Ar), 18.3 (CH2), 13.6 (CH3CH2). I.r.:
νmax 3371, 2966, 2877, 1725, 1681, 1603, 1532, 1456, 1392,
1364, 1301, 1287, 1248, 1226, 1176, 1141, 1081, 1050, 999, 918,
889, 793, 737, 698, 664 cm−1. HRMS (ESI+): found 420.2389
[calcd for C23H34NO6
+ (M + H)+ 420.2386].
Syn-7k. Oil. Rf = 0.37 (PE/Et2O 1 : 1). [α]D = −12.7 (c 0.34,
CHCl3).
1H NMR (300 MHz, CDCl3, 20 °C): δ = 8.00–7.95 (1 H,
m, H ortho to CO), 7.45 (1 H, td, J = 7.5, 1.2 Hz, H para to CO),
7.31–7.23 (2 H, m, H meta to CO), 5.96 (1 H, s, NH), 5.25 (1 H,
d, J = 4.2 Hz, CHOCO), 4.45 (1 H, td, J = 6.6, 4.2 Hz, 2-H),
4.24–4.04 (3 H, m, 5-H, CH2O), 2.63 (3 H, s, CH3Ar), 2.25 (2 H,
t, J = 7.2 Hz, CH2CO), 2.13–1.87 (3 H, m, 3-H, 4-H), 1.73–1.63
(1 H, m, 4-H), 1.62 (2 H, hexuplet, J = 7.4 Hz, CH2CH2CO), 1.35
(9 H, s, C(CH3)3), 0.91 (3 H, t, J = 7.4 Hz, CH3CH2).
13C NMR
(75 MHz, CDCl3, 20 °C): δ = 173.5 167.1, 166.0 (CvO), 140.8,
128.6 (quat.), 132.6, 131.9, 130.5, 126.0 (aromatic CH), 78.8
(C-2), 77.3 (C-5), 75.3 (CHOCO), 66.1 (CH2O), 51.4 (C(CH3)3),
36.0 (CH2CO), 28.7 (C(CH3)3), 28.0 (C-4), 27.2 (C-3), 21.8
(CH3Ar), 18.4 (CH2), 13.6 (CH3CH2). I.r.: νmax 3371, 2966, 2877,
1725, 1681, 1603, 1532, 1456, 1392, 1364, 1301, 1287, 1248,
1226, 1176, 1141, 1081, 1050, 999, 918, 889, 793, 737, 698,
664 cm−1. HRMS (ESI+): found 420.2379 [calcd for C23H34NO6
+
(M + H)+ 420.2386].
(S)-2-((Butyl)amino)-1-((2S,5R)-5-((butyryloxy)methyl)tetra-
hydrofuran-2-yl)-2-oxoethyl 2-methylbenzoate anti-7l and (R)-2-
((butyl)amino)-1-((2S,5R)-5-((butyryloxy)methyl)tetrahydrofuran-
2-yl)-2-oxoethyl 2-methylbenzoate syn-7l. It was prepared with
the general procedure C. The diastereomeric ratio was deter-
mined by 1H NMR of the crude product. No 15l was detected
in this NMR. In order to obtain the two diastereomers in pure
form, two chromatographies (PE/Et2O 4 : 5) were performed.
However, the syn diastereomer was still contaminated by 14%
of anti epimer.
Anti-7l. White solid. M.p. = 81.2–83.0 °C. Rf = 0.43 (PE/Et2O
1 : 2). [α]D = +6.9 (c 1.2, CHCl3).
1H NMR (300 MHz, CDCl3,
20 °C): δ = 8.00–7.94 (1 H, m, H ortho to CO), 7.44 (1 H, td, J =
7.5, 1.4 Hz, H para to CO), 7.31–7.23 (2 H, m, H meta to CO),
6.34 (1 H, bt, J = 4.7 Hz, NH), 5.37 (1 H, d, J = 5.3 Hz, CHOCO),
4.45 (1 H, td, J = 6.9, 5.4 Hz, 2-H), 4.20 (1 H, qd, J = 6.7, 3.8 Hz,
5-H), 4.11 and 4.06 (2 H, AB part of an ABX syst., JAB = 11.6,
JAX, JBX = 3.6, 6.4 Hz, CH2O), 3.39–3.18 (2 H, m, CH2NH), 2.62
(3 H, s, CH3Ar), 2.25 (2 H, t, J = 7.5 Hz, CH2CO), 2.13–1.93 (3 H,
m, 3-H, 4-H), 1.80–1.65 (1 H, m, 4-H), 1.62 (2 H, hexuplet, J =
7.5 Hz, CH2CH2CO), 1.55–1.20 (4 H, m, CH2CH2CH3), 0.92 (3
H, t, J = 7.4 Hz, CH3CH2). 0.91 (3 H, t, J = 7.4 Hz, CH3CH2).
13C
NMR (75 MHz, CDCl3, 20 °C): δ = 173.5, 167.5, 165.9 (CvO),
140.8, 128.6 (quat.), 132.5, 131.8, 130.6, 125.8 (aromatic CH),
78.9 (C-2), 77.8 (C-5), 74.6 (CHOCO), 65.8 (CH2O), 39.1
(CH2NH), 35.9 (CH2CO), 31.5 (CH2), 27.4 (C-4), 27.2 (C-3), 21.7
(CH3Ar), 20.0 (CH2), 18.3 (CH2CH2CO), 13.7, 13.6 (CH3CH2). I.
r.: νmax 3296, 3098, 2960, 2928, 2872, 2309, 1939, 1721, 1656,
1603, 1565, 1491, 1450, 1378, 1304, 1282, 1246, 1203, 1183,
1144, 1123, 1085, 1063, 1038, 1017, 999, 959, 942, 924, 906,
892, 872, 800, 770, 734, 697, 686, 666, 636 cm−1. HRMS (ESI+):
found 420.2390 [calcd for C23H34NO6
+ (M + H)+ 420.2386].
Syn-7l. Oil. Rf = 0.34 (PE/Et2O 1 : 2).
1H NMR (300 MHz,
CDCl3, 20 °C): δ = 8.05–7.99 (1 H, m, H ortho to CO), 7.46 (1 H,
td, J = 7.5, 1.2 Hz, H para to CO), 7.34–7.24 (2 H, m, H meta to
CO), 6.19 (1 H, bt, J = 6.3 Hz, NH), 5.38 (1 H, d, J = 3.9 Hz,
CHOCO), 4.50 (1 H, td, J = 6.9, 3.9 Hz, 2-H), 4.24–4.00 (3 H, m,
5-H, CH2O), 3.28 (2 H, q, J = 6.7 Hz, CH2NH), 2.63 (3 H, s,
CH3Ar), 2.26 (2 H, t, J = 7.5 Hz, CH2CO), 2.15–1.8 (3 H, m, 3-H,
4-H), 1.77–1.63 (1 H, m, 4-H), 1.61 (2 H, hexuplet, J = 7.5 Hz,
CH2CH2CO), 1.55–1.20 (4 H, m, CH2CH2CH3), 0.91 (3 H, t, J =
7.4 Hz, CH3CH2). 0.90 (3 H, t, J = 7.4 Hz, CH3CH2).
13C NMR
(75 MHz, CDCl3, 20 °C): δ = 173.6, 168.0, 165.9 (CvO), 141.1,
128.4 (quat.), 132.7, 132.0, 130.6, 126.0 (aromatic CH), 78.8
(C-2), 77.2 (C-5), 74.9 (CHOCO), 66.0 (CH2O), 39.1 (CH2NH),
36.1 (CH2CO), 31.5 (CH2), 28.0 (C-4), 27.3 (C-3), 21.8 (CH3Ar),
20.0 (CH2), 18.4 (CH2CH2CvO), 13.7 (CH3CH2). I.r.: νmax 3296,
3098, 2960, 2928, 2872, 2309, 1939, 1721, 1656, 1603, 1565,
1491, 1450, 1378, 1304, 1282, 1246, 1203, 1183, 1144, 1123,
1085, 1063, 1038, 1017, 999, 959, 942, 924, 906, 892, 872, 800,
770, 734, 697, 686, 666, 636 cm−1. HRMS (ESI+): found
420.2387 [calcd for C23H34NO6
+ (M + H)+ 420.2386].
((2R,5S)-5-((4-Methoxyphenoxy)methyl)tetrahydrofuran-2-yl)
methanol 8. A solution of monobutyrate 4 (773 mg,
3.82 mmol)(97% ee) in dry CH2Cl2 (30 mL) was treated with
4-methoxyphenol (1.42 g, 11.5 mmol), PPh3 (1.50 g,
5.73 mmol) and di-tert-butyl azodicarboxylate (TBAD) (20 wt%
in toluene, 6.6 mL, 5.73 mmol). The resulting yellow solution
was stirred at 35 °C overnight and the volatile components
were removed under reduced pressure. To eliminate Ph3PvO,
the crude was filtered through a silica plug, eluting with PE/
EtOAc 7 : 3 and the product was collected as a crude after
removal of the solvents. The resulting white solid was dis-
solved in MeOH (9.6 mL) and treated with 0.6 M KOH in
MeOH (9.6 mL). After stirring overnight, the solvent was
removed, and the residue was taken up with saturated aqueous
Organic Chemistry Frontiers Research Article


















































NH4Cl (30 mL) and extracted with EtOAc (3 × 20 mL). The
organic layer was washed with brine, evaporated to dryness
and chromatographed (PE/EtOAc from 1 : 1 to 4 : 6) to afford
compound 8 (884 mg, 97% over two steps) as pale-yellow oil.
Rf = 0.23 (PE/EtOAc 1 : 1). [α]D = −8.2 (c 1.06, CHCl3). 1H NMR
(300 MHz, CDCl3, 25 °C): δ = 6.90–6.79 (4 H, m, aromatics),
4.38–4.28 (1 H, m, CHCH2OPMP), 4.20–4.11 (1 H, m,
CHCH2OH), 4.03 and 3.94 (2 H, AB part of ABX system, JAB =
9.9 Hz, JAX, JBX = 3.8, 4.7 Hz, CH2OPMP), 3.84–3.77 (1 H, m,
CHHOH), 3.77 (3 H, s, OCH3), 3.53 (1 H, ddd, J = 11.7, 7.5, 4.7
Hz, CHHOH), 2.22 (1 H, dd, J = 7.5, 5.3 Hz, OH), 2.12–1.87
(4 H, m, 3-H, 4-H). 13C NMR (75 MHz, CDCl3, 25 °C): δ = 154.0,
152.8 (quat.), 115.5, 114.6 (aromatic CH), 80.3 (CHCH2OH),
78.0 (CHCH2OPMP), 70.8 (CHCH2OPMP), 65.1(CHCH2OH),
55.7 (OCH3), 28.2, 27.1 (C-3, C-4). I.r.: νmax 3435, 3049, 2917,
2873, 2060, 1591, 1506, 1457, 1288, 1226, 1180, 1034, 943, 917,
884, 823, 735, 703 cm−1. HRMS (ESI+): found 239.1283
[calcd for C13H19O4
+ (M + H)+ 239.1283].
(R) and (S)-N-(tert-Butyl)-2-hydroxy-2-((2R,5S)-5-((4-methoxy-
phenoxy)methyl)tetrahydrofuran-2-yl)acetamide anti-9 and
syn-9. Alcohol 8 (53 mg, 0.22 mmol) was oxidized following
the same procedure used for 6. Then this aldehyde was sub-
mitted to a Passerini reaction with tert-butyl isocyanide and
acetic acid, following general method A to give, after chromato-
graphy, an unseparated diastereomeric mixture (61 : 39) (by 1H
NMR) of anti and syn Passerini adducts (76 mg, 90%). This
mixture was taken up in MeOH (3 mL), H2O (0.6 mL) and Et3N
(0.6 mL). After 1 h at rt, the solvent was evaporated, and the
crude purified by preparative TLC (PE/Et2O/CH2Cl2 2 : 3 : 2) to
give pure anti-9 (37.5 mg) and syn-9 (24.0 mg). Overall yield:
91%.
Anti-9. Oil. Rf = 0.49 (PE/Et2O/CH2Cl2 2 : 3 : 2). [α]D = +23.6
(c 2, CHCl3).
1H NMR (300 MHz, CDCl3, 25 °C): δ = 6.85 (4 H, s,
aromatics), 6.76 (1 H, br s, NH), 4.41–4.32 (1 H, m, 2-H or
5-H), 4.27–4.18 (1 H, m, 2-H or 5-H), 4.14 (1 H, dd, J = 10.0, 3.3
Hz, CHHOAr), 4.06 (1 H, dd, J = 6.1, 2.5 Hz, CHOH), 3.91 (1 H,
dd, J = 10.0, 3.5 Hz, CHHOAr), 3.83 (1 H, d, J = 2.6 Hz, OH),
3.77 (3 H, s, CH3O), 2.14–1.97 (4 H, m, 3-H, 4-H), 1.32 (9 H, s,
(C(CH3)3)).
13C NMR (75 MHz, CDCl3, 25 °C): δ = 170.4 (CvO),
154.2, 152.4 (aromatic quat.), 115.4, 114.7 (aromatic CH),
80.7, 78.3 (C-2, C-5), 72.1 (CHOH), 70.0 (CH2OAr), 55.7 (OCH3),
50.9 (C(CH3)3), 28.6 (C(CH3)3), 26.9, 26.8 (C-3, C-4). HRMS
(ESI+): found 338.2005 [calcd for C18H28NO5
+ (M + H)+
338.2000].
Syn-9. Oil. Rf = 0.36 (PE/Et2O/CH2Cl2 2 : 3 : 2). [α]D = −60.1
(c 1, CHCl3).
1H NMR (300 MHz, CDCl3, 25 °C): δ = 6.91–6.81
(4 H, m, aromatics), 6.57 (1 H, br s, NH), 4.44 (1 H, td, J = 6.7,
3.5 Hz, 2-H), 4.37–4.29 (1 H, m, 5-H), 4.14 (1 H, dd, J = 9.9,
3.3 Hz, CHHOAr), 3.93 (1 H, dd, J = 6.3, 3.6 Hz, CHOH), 3.91 (1
H, dd, J = 10.0, 3.6 Hz, CHHOAr), 3.78 (1 H, d, J = 6.3 Hz, OH),
3.77 (3 H, s, CH3O), 2.16–1.9 (4 H, m, 3-H, 4-H), 1.34 (9 H, s,
(C(CH3)3)).
13C NMR (75 MHz, CDCl3, 25 °C): δ = 171.0 (CvO),
154.3, 152.6 (aromatic quat.), 115.5, 114.8 (aromatic CH), 80.0,
78.0 (C-2, C-5), 73.3 (CHOH), 70.7 (CH2OAr), 55.7 (OCH3), 50.9
(C(CH3)3), 28.7 (C(CH3)3), 28.1, 27.7 (C-3, C-4). HRMS (ESI+):
found 338.1998 [calcd for C18H28NO5
+ (M + H)+ 338.2000].
(S)-N-(tert-Butyl)-2-hydroxy-2-((2S,5R)-5-(hydroxymethyl)
tetrahydrofuran-2-yl)acetamide anti-10. Triethylamine (0.3 mL)
and H2O (0.3 mL) were added to a stirred solution of anti-7a
(105 mg, 0.31 mmol) in MeOH (1.4 mL). The reaction was
stirred at room temperature overnight and concentrated. The
residue was chromatographed with CH2Cl2/cHex/EtOAc
(3 : 2 : 2) to give anti-10 (63 mg, 89%), as a colourless oil. The
enantiomeric excess (>99%) was determined by HPLC on a
chiral stationary phase. Conditions: column Daicel Chiral Pak
AD (250 × 4.6 mm); detector DAD (210 nm). Isocratic elution
with n-hexane/isopropanol 85 : 15. Temperature: 25 °C. Rt: anti-
10: 7.18 min. anti-ent-10: 9.38 min. [α]D = −49.3 (c 1, CHCl3).
Rf = 0.22 (EtOAc/cHex 4 : 1).
1H NMR (300 MHz, CDCl3, 20 °C):
δ = 6.70 (1 H, br s, NH), 4.27–4.20 (1 H, m, 2-H), 4.20–4.08 (1 H,
m, 5-H), 4.11 (1 H, d, J = 5.1 Hz, CH-OH), 3.88 (1 H, dd, J =
11.4, 2.9 Hz, CHHOH), 3.59 (1 H, dd, J = 11.4, 3.7 Hz,
CHHOH), 2.00–1.86 (4 H, m, 3-H, 4-H), 1.37 (9 H, s, C(CH3)3).
13C NMR (75 MHz, CDCl3, 20 °C): δ = 170.4 (CvO), 80.8 (C-2),
80.0 (C-5), 72.8 (CHOH), 64.6 (CH2OH), 51.0 (C(CH3)3), 28.7
(C(CH3)3), 26.7, 26.5 (C-3, C-4). I.r.: νmax 3331, 3313, 3294,
3271, 3223, 3204, 3148, 3101, 3090, 2966, 2934, 2920, 2907,
2876, 1649, 1529, 1456, 1394, 1364, 1294, 1225, 1130, 1103,
1047, 1014, 677, 648, 621 cm−1. HRMS (ESI+): found 232.1545
[calcd for C11H22NO4
+ (M + H)+ 232.1543].
(R)-N-(tert-Butyl)-2-hydroxy-2-((2R,5S)-5-(hydroxymethyl)tetra-
hydrofuran-2-yl)acetamide anti-ent-10. A solution of anti-9
(9.6 mg, 0.028 mmol) in CH3CN (0.47 mL) and H2O (0.14 mL)
was cooled at 0 °C, and treated with (NH4)2Ce(NO3)6 (39 mg,
0.071 mmol). After 15 min the reaction was quenched by
addition of saturated aqueous NaHCO3. Extraction with
CH2Cl2 evaporation, and preparative TLC (EtOAc) gave the title
compound (4.3 mg, 66%). The enantiomeric excess (98%) was
determined by HPLC on a chiral stationary phase. For
conditions see the preparation of anti-ent-10. [α]D = +50.8
(c 1, CHCl3). The
1H NMR spectrum was identical to that of
anti-10, and different from that of syn-10 (see the preparation
of syn-22).
(S)-2-(tert-Butylamino)-1-((2S,5R)-5-(hydroxymethyl)tetrahydro-
furan-2-yl)-2-oxoethyl acetate 21. A solution of anti-7a (95 mg,
0.28 mmol) in THF (0.3 mL) and phosphate buffer 0.1 M pH 7
(1.1 mL) was treated with lipase from Candida antarctica
(CAL-B) (19 mg), and stirred at r.t. for 4 d. Then the enzyme
was filtered washing with EtOAc/H2O. The phases were separ-
ated and the aqueous phase re-extracted with EtOAc (20 mL ×
3). The organic phase was finally concentrated and chromato-
graphed (EtOAc/cHex 3 : 1), to give alcohol 21 as a white solid
(57 mg, 75%). [α]D = −6.7 (c 1, CHCl3). M.p. = 110.0–111.4 °C.
Rf = 0.21 (EtOAc/cHex 2 : 1).
1H NMR (500 MHz, CDCl3, 25 °C):
δ = 6.10 (1 H, br s, NH), 5.12 (1 H, d, J = 4.6 Hz, CHOAc), 4.21
(1 H, td, J = 6.7, 4.7 Hz, 2-H), 4.16–4.08 (1 H, m, 5-H), 3.77 and
3.46 (2 H, part AB of ABX syst., JAB = 11.9, JAX, JBX = 2.7, 3.9 Hz,
CH2OH), 2.18 (3 H, s, CH3CO), 2.15–1.85 (4 H, m, 3-H, 4-H),
1.37 (9 H, s, ((CH3)3)).
13C NMR (126 MHz, CDCl3, 25 °C,
acquired in J-MOD pulse sequence): δ = 169.3, 167.1 (CvO),
80.7 (C-2), 79.5 (C-5), 74.5 (CHOAc), 64.4 (CH2OH), 51.5
(C(CH3)3), 28.6 (C(CH3)3), 28.5, 25.9 (C-3, C-4), 21.0 (CH3CO).
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IR: νmax = 3395, 3327, 3285, 2968, 2928, 1742, 1670, 1649,
1560, 1458, 1367, 1225, 1103, 1070, 1047 cm−1. HRMS (ESI+):
found 274.1638 [calcd for C13H24NO5
+ (M + H)+ 274.1649].
(1S,2S,5R)-N-(tert-Butyl)-3,8-dioxabicyclo[3.2.1]octane-2-carbox-
amide anti-22 and (1S,2R,5R)-N-(tert-butyl)-3,8-dioxabicyclo
[3.2.1]octane-2-carboxamide syn-22. Triethylamine (0.6 mL) and
H2O (0.6 mL) were added to a stirred solution of a
76 : 24 mixture of anti-7a and syn-7a (273 mg, 0.80 mmol) in
MeOH (2.8 mL). The reaction was stirred at room temperature
overnight and concentrated. The residue was chromatographed
with CH2Cl2/cHex/EtOAc (3 : 2 : 2) to give a mixture of anti-10
and syn-10 (141 mg, 77%), as a colourless oil. Rf = 0.22 (EtOAc/
cHex 4 : 1). From the NMR of this mixture we could extrapolate
the 1H NMR of the minor syn isomer: 1H NMR (500 MHz,
CDCl3, 20 °C): δ = 6.76 (1 H, br s, NH), 4.30 (1 H, td, J = 7.0, 3.5
Hz, 5-H), 4.20–4.00 (1 H, m, 2-H), 3.89 (1 H, d, J = 3.5 Hz,
CHOH), 3.81 and 3.53 (2 H, part. AB of ABX sist., JAB = 11.6,
JAX, JBX = 2.7, 3.4 Hz, CH2O), 2.04–1.84 (4 H, m, 3-H and 4-H),
1.35 (9 H, s, (CH3)3C).
13C NMR (126 MHz, CDCl3, 25 °C): δ =
171.7 (CvO), 80.2, 80.0 (C-2 and C-5), 73.8 (CHOH), 65.1
(CH2O), 51.2 (C(CH3)3), 28.8 ((CH3)3C), 28.2, 27.3 (C-3 and
C-4). This mixture (0.61 mmol) was taken up in dry THF
(35 mL) at room temperature and treated with triphenyl-
phosphine (240 mg, 0.91 mmol) and diethyl azodicarboxylate
(60% in toluene, 416 µL, 0.91 mmol). The mixture was stirred
at room temperature for 3.5 h and then concentrated. The
crude product was eluted from a column of silica gel with
cHex/EtOAc (4 : 1 to pure EtOAc) to give anti-22 (59 mg) and
syn-22 (20 mg) (minor) (overall yield = 61%) separately.
Anti-22. White solid. [α]D = −55.7 (c 1, CHCl3). M.p. =
55.6–57.1 °C. Rf = 0.27 (cHex/EtOAc 4 : 1).
1H NMR (500 MHz,
CDCl3, 25 °C): δ = 6.32 (1 H, br s, NH), 4.58 (1 H, d, J = 6.7 Hz,
1-H), 4.21 (1 H, d, J = 3.6 Hz, 5-H), 4.09 (1 H, s, 2-H), 3.85 and
3.57 (2 H, AB syst., J = 11 Hz, 4-H), 1.98–1.74 (4 H, m, H-6 and
H-7), 1.36 (9 H, s, C(CH3)3).
13C NMR (126 MHz, CDCl3, 25 °C,
acquired in J-MOD pulse sequence): δ = 167.8 (CvO), 78.3,
76.2 (C-1 and C-5), 74.5 (C-2), 71.6 (C-4), 50.9 (C(CH3)3), 28.8
(C(CH3)3), 27.1, 24.8 (C-6, C-7). IR νmax = 3410, 2962, 2916,
2868, 1747, 1670, 1522, 1456, 1364, 1285, 1275, 1227, 1122,
1082, 1065, 1051, 1032, 1007, 995, 935, 891, 876, 818, cm−1.
HRMS (ESI+): found 214.1441 [calcd for C11H20NO3
+ (M + H)+
214.1438].
Syn-22. Foam. Rf = 0.20 (cHex/EtOAc 4 : 1).
1H NMR
(500 MHz, CDCl3, 25 °C): δ = 6.56 (1 H, br s, NH), 4.90 (1 H, d,
J = 6.6 Hz, 1-H), 4.21 (1 H, d, J = 6.0 Hz, 5-H), 3.90 (1 H, dd, J =
10.8, 1.8 Hz, 4-H), 3.69 (1 H, s, 2-H), 3.44 (1 H, dd, J = 10.8, 1.8
Hz, 4-H), 2.10–1.95 (4 H, m, H-6 and H-7), 1.40 (9 H, s,
C(CH3)3).
13C NMR (126 MHz, CDCl3, 25 °C, acquired in
J-MOD pulse sequence): δ = 168.6 (CvO), 78.1, 74.2 (C-1 and
C-5), 73.5 (C-2), 68.9 (C-4), 51.0 (C(CH3)3), 28.8 (C(CH3)3), 27.6,
26.1 (C-6, C-7). IR νmax = 2962, 2916, 2865, 1747, 1673, 1522,
1458, 1364, 1275, 1227, 1122, 1082, 1064, 1040, 1032, 1010,
995, 930, 877, 818 cm−1 HRMS (ESI+): found 214.1439 [calcd
for C11H20NO3
+ (M + H)+ 214.1438].
Theoretical calculations. Before starting DFT simulations a
conformational analysis of aldehyde 6 was carried out with the
Macromodel software (Schrödinger Release 2018-4:
MacroModel, Schrödinger, LLC, New York, NY, 2018). In par-
ticular, the OPLS353 force field was used to describe the mole-
cule surrounded by an implicit solvent model of CHCl3. All the
sampling parameters have been set to the default values.
All the conformers within a potential energy difference less
than 3 kcal mol−1 from the absolute minimum were then opti-
mized by DFT calculations. During these minimizations, the
energy of the system was described by Density Functional
Theory (DFT) using the B3LYP functional54–56 and the
LACVP**+ basis set. The convergence parameters were left at
the default values. All the DFT calculations were run by the
Jaguar program (Schrödinger Release 2018-2: Jaguar,
Schrödinger, LLC, New York, NY, 2018). Also in this case the
solvent effects were described by the Poisson Boltzmann Finite
element method (PBF) CHCl3 solvent model. The same compu-
tational set-up was used in all the subsequent DFT runs.
The conformer of 6 with the lowest energy was then used to
build a model of the possible transition states including 6,
zinc acetate and methylisocyanide. To take into account all the
possible attack trajectories to the aldehyde group, the isocya-
nide was initially placed on the two sides of the plane defined
by the atoms of the aldehyde group. During these calculations
the distance between the zinc ion and the aldehyde oxygen,
the zinc ion and the isocyanide carbon, the aldehyde carbon
and the isocyanide carbon, were firstly restrained to an
optimal value of 2.5 Å. Finally, the two models were structu-
rally optimized without any restraint.
Then a relaxed potential energy scan (RPES) was carried out
considering the distance between the carbonyl carbon atom
and the carbon atom of the isocyanide as collective variable
(CV). In particular, the distance has been sequentially shor-
tened of 0.4 Å from an initial value of 5 Å to a final value of
1.4 Å. After every movement, the resulting structure has been
optimized by energy minimization blocking the CV distance at
the desired value and leaving the other atoms free to move.
Finally, the structure corresponding to a CV of 1.4 Å was opti-
mized without any restraint to obtain the structure showed in
Fig. 1C.
The Wiberg bond orders were calculated by their Jaguar
implementation.57
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